Regenerative Medicine Best Practices for Patient Optimization

Understand the importance of patient optimization in regenerative medicine and its role in modern healthcare advancements.

Abstract

Hello, I’m Dr. Alex Jimenez. With my extensive background in integrative and functional medicine, holding titles including DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, I’ve dedicated my career to optimizing patient health from every angle. In this educational post, we will journey through the critical yet often overlooked phase of preparing the body for orthobiologic and regenerative therapies. I believe that optimizing the patient’s internal environment—their personal “pharmacy”—is just as crucial as the biologic treatment itself. We will explore the six pillars of lifestyle medicine: diet, exercise, sleep, stress mitigation, social connectedness, and the avoidance of risky substances. Drawing on the latest evidence-based research, we’ll discuss how conditions such as obesity, chronic low-grade inflammation, sarcopenia, and gut dysbiosis can significantly affect the success of regenerative procedures. I will provide a comprehensive framework for assessing and enhancing a patient’s metabolic health, including specific dietary recommendations, exercise protocols, and screening tools. We will also delve into how integrative chiropractic care complements this process by addressing the biomechanical and neurological factors that influence healing, ensuring a truly holistic approach to recovery and long-term wellness.

The Foundation of Healing: Why Patient Optimization is Non-Negotiable

As a practitioner deeply invested in both chiropractic and functional medicine, my perspective is uniquely shaped by a diverse background that includes public health and a passion for holistic wellness. When a patient comes to me for an orthobiologic procedure, my focus isn’t just on the treatment itself. It extends to a fundamental question: Is this patient’s body prepared to heal? I am passionate about making sure every patient is as metabolically optimized as possible before we proceed.

Think of it this way: the biologics we use, whether platelet-rich plasma (PRP) or cellular therapies, are catalysts. But the real work of healing happens within the patient’s own body. We are, in essence, optimizing their internal pharmacy. By improving their metabolic health, we are ensuring that the “raw materials” for regeneration are abundant and that the environment is conducive to repair rather than breakdown. This concept is the cornerstone of my practice and is supported by a growing body of research highlighting the profound connection between lifestyle and regenerative potential.

The Six Pillars of Lifestyle Medicine in Regenerative Care

To structure this optimization process, I use the framework of lifestyle medicine. This evidence-based approach focuses on six key areas that collectively determine our overall health. When we improve these pillars, we achieve maximum metabolic optimization, creating the ideal conditions for regenerative treatments to succeed. While we have few, if any, large-scale randomized controlled trials (RCTs) directly linking these pillars to biologic outcomes, a wealth of data from other fields allows us to extrapolate and apply these principles with confidence. We know, for instance, that dietary interventions can improve platelet function and that exercise can enhance cellular activity (Paolucci et al., 2023).

Here are the six pillars we focus on:

Diet and Nutrition: Fueling the body for repair.
Physical Activity: Moving to enhance cellular function.
Restorative Sleep: The non-negotiable recovery phase.
Stress Management: Taming the silent saboteur of healing.
Social Connection: The powerful influence of community on health.
Avoidance of Risky Substances: Eliminating toxins that hinder regeneration.

Identifying and Addressing Key Barriers to Healing

A pivotal review article has identified six specific aspects of health that can significantly influence the outcomes of our procedures (Centeno et al., 2023). Our goal is to ensure that patients walk away from our care not just with temporary relief but with a profound, lasting improvement in their quality of life. By addressing these factors, we build a reputation for excellence.

These six critical aspects are:

Obesity: Excess weight doesn’t just add mechanical stress to joints. For every pound of weight lost around the midsection, there’s a roughly four-fold decrease in the load on the knee joint. But beyond the mechanics, obesity is a state of metabolic dysregulation, characterized by adipokines—inflammatory molecules secreted by fat cells—that create a hostile environment for healing.
Chronic Low-Grade Inflammation: This isn’t the acute, beneficial inflammation that initiates healing after an injury. This is a persistent, systemic inflammation that slowly degrades tissues and impairs regenerative processes.
Sarcopenia: the age-related loss of muscle mass and function. Muscle is a metabolic powerhouse, and its decline compromises the body’s ability to heal and maintain stability.
Gut Dysbiosis: This term describes an imbalance in your gut microbiota—the trillions of microorganisms living in your digestive tract. When these communities are out of balance, they can produce toxic byproducts that leak into the bloodstream, driving systemic inflammation and disrupting immune function.
Sleep Deprivation: Anyone with a child understands how crucial sleep is. Lack of sleep dysregulates key hormones like cortisol, impairs immune function, and heightens pain sensitivity.
Unhealthy Lifestyle Behaviors: A patient might be a marathon runner, but if they are also smoking heavily, the toxic exposure will negate many of the benefits. We must look at the patient’s life in its entirety.

Fueling Regeneration: The Power of an Anti-Inflammatory Diet

Your diet is one of the most powerful tools for influencing your body’s internal environment. We know that conditions like obesity and insulin resistance are detrimental, leading to impaired cellular function and a reduced capacity for healing. This is because high blood sugar and insulin levels create a pro-inflammatory state hostile to the very regeneration we aim to stimulate.

The gut-body connection is another critical piece of the puzzle. An imbalanced gut microbiome, or gut dysbiosis, can directly contribute to systemic inflammation, sabotaging our efforts. I believe we are only scratching the surface of how the gut impacts musculoskeletal health, and future research will undoubtedly reinforce this link.

Proposed Dietary Approach

My recommendation for patients is to adopt an anti-inflammatory diet. This isn’t a fad; it’s a dietary pattern that has been used successfully for years in rheumatology to manage inflammatory arthritis. The principles are simple and effective:

Increase Fiber and Leafy Greens: These feed beneficial gut bacteria and are rich in phytonutrients that help combat inflammation.
Boost Omega-3 Fatty Acids: Found in fatty fish, flaxseeds, and walnuts, these fats are precursors to powerful anti-inflammatory molecules.
Focus on Low-Glycemic-Index Foods: Choose whole grains, legumes, and non-starchy vegetables to help stabilize blood sugar and insulin levels.
Ensure Adequate Protein Intake: Protein provides the essential amino acids needed for tissue repair and collagen synthesis.
Avoid Processed Foods and Refined Sugars: These are primary drivers of inflammation and metabolic dysfunction.

Do We Need Supplements?

For a patient eating a varied, whole-foods diet, supplementation is often unnecessary. However, if there are concerns about nutritional gaps, certain nutrients can be particularly helpful:

Vitamin C: Essential for collagen synthesis, the primary protein in our connective tissues.
Vitamin D & Magnesium: Crucial for muscle function, bone health, and immune regulation.
Zinc & Copper: These minerals are cofactors in numerous enzymatic reactions vital for tissue repair.
Probiotics: Can help restore balance to the gut microbiome, potentially reducing systemic inflammation.

It’s important to note that the evidence regarding supplementation in relation to orthobiologic procedures is mixed. Some studies may suggest discontinuing certain supplements before a procedure, so it is always best to work with a knowledgeable provider to create a personalized plan.

Movement as Medicine: Exercise Protocols for Enhanced Healing

Exercise is a potent medicine that positively impacts every barrier to healing we’ve discussed. It combats obesity and insulin resistance, lowers chronic inflammation, improves sleep quality, and reverses sarcopenia.

From an orthobiologic perspective, the benefits are even more direct:

Optimize Cellular Quality: Exercise can increase platelet counts and even enhance growth factor concentrations within platelets.
Improve Tissue Responsiveness: Regular physical activity makes your tissues more receptive to the growth signals initiated by regenerative treatments.
Limit Cellular Senescence: Exercise helps clear out old, dysfunctional “zombie” cells and improves the function, replication, and differentiation capacity of your own mesenchymal stem cells (MSCs).

Exercise Recommendations

As part of my intake, I use what’s called an “exercise vital sign,” a quick two-question screen to gauge a patient’s activity level. The goal is to meet or exceed the following recommendations:

Aerobic Exercise: At least 150 minutes per week of moderate-intensity activity (e.g., brisk walking, cycling). I often tell my patients that while this is the ideal, any movement toward this goal is a step in the right direction.
High-Intensity Interval Training (HIIT): Incorporating short bursts of intense effort followed by recovery periods is particularly effective at improving endothelial function—the health of your blood vessel lining—which is critical for delivering nutrients and healing factors to tissues.
Resistance Training: Aim for at least two sessions per week. Building and maintaining muscle is metabolically protective and provides crucial support for our joints.
Pre-Procedure Exercise: Intriguing research suggests that an acute bout of high-intensity exercise immediately before a PRP blood draw can temporarily increase circulating platelet levels (Liao et al., 2021). This is a simple strategy I often incorporate, having patients perform a short workout at a nearby gym just before their appointment.

The Healing Diet: Combat Inflammation, Embrace Wellness- Video

The Critical Role of Restorative Sleep

Sleep is when the body’s most important repair processes occur. The standard recommendation of seven to nine hours per night is not arbitrary; it’s a biological necessity. Inadequate sleep disrupts the delicate balance of our endocrine system, particularly affecting cortisol regulation. While often vilified, cortisol plays a vital role in managing inflammation, but chronically elevated levels due to poor sleep suppress the very pro-inflammatory signals needed to kickstart healing.

Furthermore, poor sleep significantly impacts central pain modulation. A sleep-deprived patient will perceive more pain from the procedure and during recovery. In my clinical observations at our clinics, patients who prioritize sleep hygiene consistently report better pain control and smoother recoveries. Special attention should be paid to conditions like obstructive sleep apnea (OSA), which can cause endothelial dysfunction due to intermittent hypoxia (low oxygen levels). I routinely screen for OSA, and it’s not uncommon for this screening to lead to a new diagnosis and life-changing treatment for a patient.

Eliminating Toxic Burdens: Tobacco and Alcohol

I am very direct with my patients about this: tobacco and alcohol are Group 1 carcinogens, meaning they are definitively known to cause cancer. Their negative impact on healing is just as definitive.

Tobacco: Nicotine is directly cytotoxic to MSCs (your stem cells) and causes abnormal platelet aggregation. It constricts blood vessels, starving tissues of the oxygen and nutrients they desperately need to heal.
Alcohol: Extensive surgical data shows that alcohol consumption increases the risk of post-procedure infection and impairs wound healing. It also directly damages MSCs and depletes key nutrients.

My approach is to counsel patients frankly about these risks and connect them with resources such as quit lines, pharmacotherapy, or a referral back to their primary care provider to develop a cessation strategy. A regenerative procedure is a significant investment of time, money, and hope—it makes no sense to undermine it with toxic exposures.

The Biopsychosocial Model: Stress, Social Connection, and Pain

The mind-body connection is not a new-age concept; it is a biological reality. Chronic stress leads to elevated cortisol levels, which, as we’ve discussed, impair tissue healing, suppress beneficial inflammation, and restrict the proliferation and differentiation of MSCs.

Conversely, strong social connections and effective stress management techniques are powerful buffers. Much of the data in this area revolves around pain mitigation. Patients who feel supported, understood, and emotionally resilient experience less pain and have better functional outcomes. This is why I advocate for a biopsychosocial evaluation, where we assess for stress, anxiety, and depression. It is crucial, however, that if you screen for these conditions, you must have the resources in place to provide or refer for appropriate support, such as behavioral health counseling. You can’t just ask the question and leave the patient hanging.

The Role of Integrative Chiropractic Care

This is where the principles of integrative chiropractic care fit seamlessly into the patient optimization plan. While functional medicine addresses the body’s biochemistry, chiropractic care focuses on its biomechanics and neurology. The two are inextricably linked.

Restoring Biomechanical Function: A misaligned joint or dysfunctional movement pattern places abnormal stress on tissues. This chronic mechanical strain can perpetuate inflammation and create a “stuck” point that resists healing, even with biologics. Through precise spinal and extremity adjustments, we restore proper joint mechanics, unload compromised tissues, and create a better environment for regenerative cells to work.
Improving Neurological Input: Chiropractic adjustments have a profound effect on the nervous system. By stimulating mechanoreceptors in the joints and soft tissues, we can downregulate pain signals (nociception) and improve proprioception (the body’s sense of its position in space). This helps break the chronic pain cycles that often accompany degenerative conditions and can improve a patient’s tolerance for rehabilitative exercise.
Enhancing Blood Flow and Fluid Dynamics: Proper movement is essential for pumping blood and lymphatic fluid, which deliver nutrients and remove waste products. Chiropractic care, combined with soft-tissue modalities, helps release restrictions and improve circulation in the target area, ensuring that regenerative therapies are delivered where they are needed most.

By integrating chiropractic adjustments, we are not just treating the site of injury; we are optimizing the entire kinetic chain and the neurological signaling that governs it. This ensures the patient’s body is mechanically and neurologically receptive to healing.

A Practical Approach to Pre-Procedure Assessment

So, how do we put all this into practice? It starts with a thorough assessment. If a patient’s recent medical records (within the last six months) are available and appear to be in good condition, extensive new testing may not be needed. However, I typically start with some simple point-of-care measurements.

Initial Screening:

Vitals: Height, weight, blood pressure, and waist circumference (a key indicator for metabolic syndrome).
Point-of-Care Labs: A fasting glucose and a lipid panel can quickly identify or rule out metabolic syndrome. Key markers are triglycerides and HDL cholesterol.
Further Labs (if indicated): Based on the initial screen and patient history, I might order a Hemoglobin A1c (to assess long-term blood sugar control), C-Reactive Protein (CRP, a marker of inflammation), or a renal function panel.

Screening Questionnaires:

Validated questionnaires are an efficient way to gather crucial information:

Lifestyle: Simple screens for tobacco/alcohol use, exercise, and diet.
Sleep: Questionnaires like the STOP-BANG can screen for sleep apnea risk.
Mental Health: Tools to assess for stress, anxiety, and depression (e.g., PHQ-9, GAD-7).

Creating an Optimization Plan

Based on this comprehensive assessment, I classify a patient’s metabolic risk as low, moderate, or high.

Low Risk: A patient with no signs of metabolic syndrome.
High Risk: A patient presenting with, for example, a Hemoglobin A1c of 11% and uncontrolled hypertension.

For a patient with moderate-to-high metabolic risk who is otherwise a good candidate for a biologic procedure (e.g., rotator cuff tendinopathy), this is the perfect opportunity to intervene. I present them with the information, we establish baseline markers, and we collaboratively set a timeline—often 8 to 12 weeks—to focus on optimization. We then repeat the key markers to track progress. This process of shared decision-making empowers the patient and dramatically increases their chances of a successful outcome.

The optimization “prescription” might include:

Specific Exercise Goals: “You need to achieve 150 minutes of brisk walking per week.”
Dietary Counseling: Providing clear guidelines or referring to a registered dietitian.
Sleep Hygiene Strategies.
Stress Mitigation Techniques: Recommending mindfulness apps, deep breathing exercises, or a referral for counseling.
Cessation Support: For tobacco and alcohol use.

This pre-habilitation period is an investment that pays dividends long after the procedure, fostering lifestyle changes that promote lifelong health. Thank you for joining me on this exploration of patient optimization.

References

Centeno, C., Money, J., & Bashir, J. (2023). A narrative review of the influence of metabolic, lifestyle, and nutritional factors on autologous orthobiologic outcomes. Journal of Prolotherapy, 15(e-pub). Hyperlinked: https://journalofprolotherapy.com/a-narrative-review-of-the-influence-of-metabolic-lifestyle-and-nutritional-factors-on-autologous-orthobiologic-outcomes/
Liao, H. T., Chen, Y. C., & Lee, C. L. (2021). Effects of exercise on platelet-rich plasma. Formosan Journal of Musculoskeletal Disorders, 12(2), 33-38. Hyperlinked: https://www.fjsmd.com/article/S2074-6869(21)00003-8/fulltext
Paolucci, T., Pezzi, L., Centofanti, A., Giglio, M., Cáprio, M., & Fini, M. (2023). The influence of nutrition and physical activity on osteoarthritis. International Journal of Environmental Research and Public Health, 20(4), 3658. MDPI. Hyperlinked: https://www.mdpi.com/1660-4601/20/4/3658

SEO Tags: regenerative medicine, orthobiologics, patient optimization, lifestyle medicine, integrative chiropractic, platelet-rich plasma, PRP, stem cell therapy, metabolic health, anti-inflammatory diet, gut dysbiosis, sarcopenia, chronic inflammation, exercise physiology, sleep hygiene, stress management, functional medicine, Dr. Alex Jimenez, chiropractic care, holistic healing

May 29, 2026

How PRP Concentration Impacts Tissue Healing

Abstract

In the ever-evolving landscape of regenerative medicine, platelet-rich plasma (PRP) has emerged as a cornerstone therapy for a multitude of musculoskeletal conditions, most notably osteoarthritis. However, the clinical conversation is shifting from a simple “yes or no” regarding its use to a more sophisticated understanding of “how” and “why” it works. This post will take you on an educational journey into the nuanced world of PRP therapy. We will explore the critical concepts of platelet concentration, the evolving debate over leukocyte ratios (leukocyte-rich vs. leukocyte-poor PRP), and the latest evidence-based findings reshaping our treatment protocols. Drawing upon modern research and my clinical observations, we will demystify the physiological mechanisms at play, explaining how we can optimize treatments by focusing on absolute platelet dosage and understanding the synergistic roles of different cell types. Furthermore, we will connect these advanced regenerative techniques to the foundational principles of integrative chiropractic care, illustrating how a comprehensive approach that addresses biomechanical integrity and systemic health is paramount for achieving lasting patient outcomes.

The Evolution of PRP: Beyond Leukocyte Ratios to Precise Dosing

For years, the regenerative medicine community has engaged in a robust discussion about the ideal formulation of PRP. A central point of this debate was the white blood cell (leukocyte) ratio in the PRP preparation. This led to the common classification of PRP into leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) subtypes. The prevailing thought was that one type might be superior for specific conditions—for instance, that the pro-inflammatory nature of leukocytes in LR-PRP could be detrimental for an already inflamed arthritic joint.

This classification system, born around 2011-2012, was a significant step forward. It gave us a framework to begin conceptualizing and comparing different PRP preparations. It was a way for clinicians like myself to ask, “What is our patient actually receiving?” However, as science progresses, so must our understanding.

A Paradigm Shift in Understanding

Recent research has begun to challenge this dichotomous view. In a fascinating turn, some of the very same researchers who first proposed the importance of leukocyte ratios published a pivotal paper around 2022. Their updated findings, specifically regarding joint arthritis, suggested that, in the long run, the distinction between leukocyte-rich and leukocyte-poor PRP may not be as critical as we once believed (Le et al., 2022).

This finding aligns with a growing body of evidence that points to a different, perhaps more crucial, variable: the absolute platelet dose. Instead of focusing solely on the cell ratio, the focus is shifting to the total number of platelets delivered to the target tissue. The question is evolving from “Is it rich or poor in leukocytes?” to “How many billion platelets are we administering?” This represents a significant paradigm shift, moving us toward a more precise, dose-dependent approach to regenerative therapy.

In my own practice, I’ve observed this principle in action. A recent case involved a patient for whom we prepared PRP with a concentration factor of approximately 7.5 times their baseline platelet count. While this number can vary from patient to patient due to individual physiology, our advanced processing systems consistently yield concentrations in the 6x-10x range. The key was not just the concentration but the processing method, which allowed us to capture a high platelet yield, ensuring we delivered a therapeutically significant dose.

The Intricate Cellular Symphony Within PRP

To truly appreciate the power of PRP, we must look at the intricate components of the preparation and how they work together. Using modern separation systems, we can meticulously isolate different fractions of the blood.

Understanding the Buffy Coat and Its Components

When blood is centrifuged, it separates into three main layers:

Red Blood Cells (Erythrocytes): The dense bottom layer.
Platelet-Poor Plasma (PPP): The clear, liquid top layer.
The Buffy Coat: A thin, whitish layer sandwiched between the other two.

The buffy coat is the treasure trove of regenerative medicine. It is densely packed with platelets and most leukocytes. The historical fear was the inclusion of the reddish layer just below the buffy coat, as it was thought to contain pro-inflammatory cells that could worsen conditions like arthritis.

However, our understanding of these cells has become much more refined. Advanced analysis reveals that this reddish zone, while containing some red blood cells, is also rich in specific leukocyte types, namely lymphocytes and monocytes. Far from being purely detrimental, these cells play a vital, beneficial role in the healing cascade.

Monocytes are particularly fascinating. When introduced to an injury site, they can differentiate into macrophages, which are essential for clearing cellular debris. More importantly, they help orchestrate the subsequent regenerative phases. The presence of lymphocytes helps guide these monocytes toward a pro-regenerative (M2) phenotype rather than a pro-inflammatory (M1) one.

This means that a PRP preparation that strategically includes these cell populations can create a more robust and sophisticated healing signal. The lymphocytes and monocytes don’t just add to the inflammation; they help manage it and then initiate a structured, beneficial healing response. This is why the conversation is moving away from simply labeling PRP as “leukocyte-rich.” It’s about understanding which leukocytes are present and their specific functions. The granulocytes (like neutrophils), which are more associated with acute inflammation, are largely separated out, while the beneficial monocytes and lymphocytes are retained.

This new perspective helps explain a retrospective observation: systems that produced “leukocyte-rich” PRP often happened to capture more platelets. The superior outcomes seen in some studies using LR-PRP for tendon injuries, for example, may have been less about the leukocytes and more about the higher absolute platelet dose being delivered (Filardo et al., 2018).

The Crucial Role of Integrative Chiropractic Care

Advanced regenerative treatments like PRP are powerful tools, but they do not exist in a vacuum. To achieve the best possible outcomes, we must address the entire patient, including the underlying biomechanical and structural issues that contributed to the injury or degeneration in the first place. This is where integrative chiropractic care becomes an indispensable partner to regenerative medicine.

Imagine injecting a highly potent, regenerative PRP preparation into a knee joint that is suffering from osteoarthritis. If that knee remains misaligned, with improper patellar tracking and imbalanced forces from dysfunctional muscles in the hip and ankle, the regenerative therapy is fighting an uphill battle. The very same pathological forces that wore down the cartilage remain, poised to degrade the newly formed tissue.

Creating an Optimal Healing Environment

As a chiropractor and functional medicine practitioner, my approach is to create an optimal environment for these regenerative cells to do their work. This involves a multi-faceted strategy:

Biomechanical Correction: Through precise chiropractic adjustments, we restore proper joint alignment not just in the affected joint but along the entire kinetic chain. For a knee issue, this means assessing and correcting imbalances in the spine, pelvis, hips, and ankles. This ensures that forces are distributed evenly, reducing pathological stress on the healing tissues.
Myofascial Release and Rehabilitation: We use advanced soft-tissue techniques to release adhesions, correct muscle imbalances, and restore proper function. This might involve active release techniques, instrument-assisted soft tissue mobilization, and targeted therapeutic exercises. This step is crucial for ensuring the joint is supported by a strong, balanced, and functional muscular system.
Nutritional and Metabolic Support: Healing is a metabolically demanding process. Through a functional medicine lens, we assess and optimize the patient’s nutritional status. This includes ensuring adequate levels of key vitamins and minerals (like Vitamin C, Zinc, and Magnesium) and managing systemic inflammation through diet and targeted supplementation (e.g., omega-3 fatty acids, curcumin). A systemically inflamed body will have a blunted response to any localized regenerative therapy.

By integrating these approaches, we are not just treating the site of pain; we are re-establishing the foundation for health. The chiropractic adjustments and physical rehabilitation prepare the “soil” by correcting the biomechanical environment, while the PRP injection acts as the “seed,” providing the cellular machinery for growth and repair. This comprehensive model significantly enhances the potential for long-term success and is a core tenet of my clinical philosophy at Injury Medical & Chiropractic Clinic.

A New Frontier in Regenerative Orthopedics

We stand at an exciting new frontier in the treatment of musculoskeletal conditions. The science of PRP is moving beyond simplistic classifications and toward a more sophisticated, evidence-based approach centered on precise dosing and a deeper understanding of cellular interactions. The latest research from leading experts is guiding us to optimize our methods, not by eliminating certain cells, but by understanding how to harness their synergistic potential to orchestrate a powerful healing response.

For patients suffering from conditions like joint arthritis, this means more effective and reliable outcomes. By combining these cutting-edge regenerative therapies with the foundational principles of integrative chiropractic care, we can address both the symptoms and the root cause of their condition. This holistic approach ensures that we are not only repairing damaged tissue but also restoring function, improving biomechanics, and empowering the body’s innate capacity to heal itself, resulting in lasting relief and improved quality of life.

References

Filardo, G., Di Matteo, B., Kon, E., Merli, G., & Marcacci, M. (2018). Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surgery, Sports Traumatology, Arthroscopy, 26(7), 1984–1999. https://doi.org/10.1007/s00167-016-4261-4

Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2022). Current clinical recommendations for use of platelet-rich plasma. Current Reviews in Musculoskeletal Medicine, 15(6), 442–453. https://doi.org/10.1007/s12178-022-09787-z

May 21, 2026

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Abstract

Welcome to this in-depth exploration of Platelet-Rich Plasma (PRP) therapy. My name is Dr. Alexander Jimenez, and in this educational post, we will journey together through the intricate world of regenerative medicine. We will unravel the complexities of PRP, moving beyond the surface-level understanding to explore the crucial details that determine its success. I will guide you through the latest findings from leading researchers, breaking down concepts like platelet dosing, the composition of the biologic product, and why not all PRP is created equal. We will discuss the physiological underpinnings of PRP, from the cellular level to its effects on tissues such as tendons and joints. A significant focus will be on the importance of achieving a specific therapeutic dose to elicit a healing response, particularly in conditions like osteoarthritis (OA) and soft tissue injuries. We will also examine how factors like patient age and the specific preparation system used can dramatically influence outcomes. Furthermore, I will explain how integrative chiropractic care plays a vital supportive role in this process, enhancing recovery and optimizing the body’s response to treatment. This post is designed to provide you with a comprehensive, evidence-based understanding of PRP therapy, empowering you to make informed decisions about your health.

As a clinician with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my goal is to bridge gaps across healthcare fields to provide a truly holistic and effective treatment model. My clinical experience, available at chiromed.com and detailed on my LinkedIn profile, has consistently shown me the power of combining advanced biologic treatments with foundational care. Let’s begin our journey into the science of PRP.

What Is a Platelet and Why Does It Matter?

To truly grasp the power of PRP, we have to go back to a fundamental concept from our early science education: what is a platelet? Many of us remember them as tiny components of our blood that help with clotting. But they are so much more than that.

Platelets are small, anucleated (meaning they lack a nucleus) cell fragments that are essentially little packets filled with a treasure trove of proteins. These proteins include powerful growth factors and cytokines, which are signaling molecules that orchestrate the body’s natural healing and repair processes.

Key Characteristics of Platelets:
- They have a lifespan of about 7 to 10 days. This is a critical piece of information. When I advise patients to avoid anti-inflammatory medications like NSAIDs before a PRP procedure, it’s because these drugs can inhibit platelet function, and we need their full healing potential for the therapy to be effective.
- A normal platelet count in the blood ranges from about 150,000 to 400,000 per microliter.
- The FDA’s definition of PRP is simply a platelet concentration that is “above baseline.” This vague definition is partly why there is so much variability in the PRP products available today.

The core principle of PRP therapy is to concentrate these powerful healing cells and their associated growth factors and then deliver them with precision to an area of injury or degeneration. The goal is to amplify the body’s natural healing cascade, transforming a chronic, non-healing state into an active, acute healing phase.

The Problem of Variability in PRP Preparations

A significant challenge in the field of regenerative medicine is the immense variability among different PRP systems. This is a critical point that both patients and practitioners must understand. The idea that “PRP is PRP” is a dangerous oversimplification.

A compelling study by Jaewoo Pak and his colleagues highlighted this issue perfectly. They analyzed five different commercial PRP systems and found dramatic differences in both the final platelet concentration and the white blood cell (WBC) count in the final product (Pak et al., 2017).

I often show my patients a slide from a presentation by Dr. Gerben van de Meijden that drives this point home. It shows the blood of a single patient processed through four different systems. The resulting PRP products are all different colors—from light yellow to deep red—each representing a unique cellular makeup. This isn’t just an aesthetic difference; it signifies a profound variability in the biologic drug we are creating. The “dose” and “formulation” are completely different, which inevitably leads to different clinical outcomes.

The Evidence for PRP: A Growing Body of Research

Despite the variability, the evidence supporting PRP therapy, particularly for certain conditions, is robust and growing. When colleagues or patients ask about the evidence, I point out a fascinating fact: there are now more patients enrolled in high-quality clinical trials for PRP in knee osteoarthritis (OA) than for hyaluronic acid injections, a long-standing and widely accepted treatment.

This wealth of data, as highlighted in a meta-analysis by Meheux et al. (2016), generally shows that PRP therapy tends to outperform hyaluronic acid, especially for medium- to long-term pain relief and functional improvement. This suggests that PRP is not just a temporary fix but may have a more lasting biological effect.

How We Create Your Personalized PRP Treatment in Our Clinic

So, how do we go from a simple blood draw to a powerful healing injectate? Let me walk you through the process we use in our clinic, which is designed for precision and quality.

Blood Draw: We begin by drawing a specific volume of your blood. This is not a one-size-fits-all step. The amount of blood we draw is a strategic decision based on the target dose we need to achieve. A larger blood volume allows us to harvest a greater total number of platelets.
First Centrifugation: The blood is placed into a sterile, closed-system kit. This kit is then placed in a centrifuge, a machine that spins at high speeds. This first “hard spin” uses centrifugal force to separate the blood into its different components based on their density. The heavier red blood cells are forced to the bottom, the lighter plasma rises to the top, and a thin, precious layer forms in the middle. This is the “buffy coat.”
Isolating the Buffy Coat: The buffy coat is where the magic is. It’s incredibly rich in platelets and white blood cells. The plasma above it, known as platelet-poor plasma (PPP), is carefully removed.
Second Centrifugation & Concentration: We are then left with the buffy coat and a small amount of plasma. In some systems, a second, slower spin is used to further concentrate the platelets. The key is understanding exactly where the platelets reside within the tube. In the system I often use, about 85% of the platelets are concentrated within a tiny 2-millimeter layer. This allows us to create a high concentration of platelets in a very small, precise volume.

Understanding the specific mechanics of the system you use is paramount. It’s the only way to reliably create a therapeutic product and move away from guesswork.

The Critical Concept of PRP Dosing

I encourage my patients and colleagues to think of PRP not as a generic “procedure” but as a biologic drug. And like any drug, it has a dose-response relationship. There is a minimum dose—a therapeutic threshold—that must be reached to trigger a significant biological effect. If the dose is too low (subtherapeutic), the treatment is likely to fail.

So, what is the right clinical dose of PRP? This is the million-dollar question, and the answer is slowly being pieced together by dedicated researchers. The optimal dose likely varies by the type of tissue being treated (e.g., tendon vs. cartilage) and the specific pathology.

Dosing for Tendons and Soft Tissues

Early research in cell cultures provided the first clues. Studies have shown that a specific platelet concentration stimulates the proliferation of tenocytes (tendon cells). However, if the concentration became too high, it had an inhibitory effect, slowing cell growth. This established the concept of an optimal therapeutic window.

A landmark study from Dr. Peter Everts’ group provided crucial clinical insight (Everts et al., 2020). They analyzed numerous studies on soft-tissue applications of PRP and plotted the results on a graph. They found a clear dividing line.

Studies that used a total platelet dose of less than approximately 3.5 billion platelets were overwhelmingly negative; the treatment didn’t work.
Studies that used a dose above 3.5 billion platelets were overwhelmingly positive.

This gives us a tangible target. If a PRP system produces only 1.5 billion platelets, it’s likely to be subtherapeutic for many soft-tissue applications. We need to aim for a dose within that effective range to give our patients the best chance of success.

How Patient Age Impacts Dosing

Here is where personalized medicine becomes essential. We know that a patient’s biology changes with age. As we get older, our baseline platelet count may decrease, and the concentration of growth factors within those platelets may also decline. This means that to achieve the same therapeutic dose of 5 billion platelets, an older patient may require a larger initial blood draw than a younger patient. In my practice, I often err on the side of drawing a larger volume of blood from my older patients to ensure we can formulate a sufficiently potent biologic product to stimulate a robust healing response. We are still in the early days of understanding these nuances, but it’s a critical consideration for candidacy and treatment planning.

Dosing for Knee Osteoarthritis (OA)

The knee is perhaps the area where we have the most data on PRP dosing. A widely cited study, the RESTORE trial, published in JAMA, concluded that PRP was no better than a saline placebo for knee OA (Bennell et al., 2021). However, a critical look at the study’s methodology reveals the flaw. They used a low-dose PRP system that delivered only 1.6 billion platelets. Based on our dose-response curve, we now understand this was a subtherapeutic dose, so a negative result was predictable. This study, while well-executed, taught us a valuable lesson about the importance of dose.

In stark contrast, another major study from Dr. Van der Weegen’s group used a dose of 10 billion platelets (van der Weegen et al., 2016). In these patients, they observed not only significant improvements in pain and function but also MRI evidence that PRP may have slowed the progression of cartilage loss. This suggests a potential disease-modifying effect at the right dose.

So, for knee OA, the evidence points to a target dose of 5 to 10 billion platelets to achieve both symptom relief and potential structural benefits.

Beyond Platelets: The Role of White and Red Blood Cells

While platelets are the star players, they are not the only cells in the PRP formulation. We must also consider the other cellular components, particularly white blood cells (WBCs) and red blood cells (RBCs).

The two main types of WBCs we are concerned with are neutrophils and monocytes. They seem to have very different effects.

Neutrophils are highly pro-inflammatory. A PRP product rich in neutrophils (leukocyte-rich PRP, or LR-PRP) often causes a more intense post-injection inflammatory reaction, with greater pain and swelling. In some cases, this intense inflammatory signal may be desirable to “kick-start” healing in a very chronic, stagnant tissue. However, there are concerns that enzymes released by neutrophils could damage certain tissues, such as articular cartilage.
Monocytes are considered more “anabolic” or constructive. They play a key role in transitioning from the inflammatory phase to the proliferative, or rebuilding, phase of healing.

The debate between leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) is ongoing. Much of the European data suggests that for a condition like knee OA, there may not be a significant clinical difference in the long run. However, the initial patient experience is often different, with LP-PRP typically being better tolerated. In my practice, the choice between LR-PRP and LP-PRP is a clinical decision based on the specific tissue, the chronicity of the injury, and the individual patient.

The Integral Role of Chiropractic Care and Rehabilitation

A PRP injection is not a magic bullet; it is a catalyst. To fully realize its potential, it must be supported by a comprehensive treatment plan. This is where integrative chiropractic care becomes a cornerstone of success.

1. Precision and Guidance: The biologic product must be delivered to the exact site of injury. If you are treating a rotator cuff tear, the PRP must be placed directly into the defect within the tendon. If it’s injected into the surrounding bursal space, it cannot perform its function of forming a biological scaffold and stimulating repair. This is why ultrasound guidance is non-negotiable for these procedures. It ensures that this precious biologic drug gets to its target.

2. Optimizing Biomechanics: As a chiropractor, my focus is on function and structure. If a patient has knee OA due to poor hip mechanics or foot overpronation, simply injecting the knee only addresses the symptom. Chiropractic adjustments, soft tissue mobilization, and corrective exercises are crucial for addressing the underlying biomechanical faults that led to the joint breakdown in the first place. This creates a better environment for the PRP to work and helps prevent recurrence of the injury.

3. Guided Rehabilitation: The post-injection period is critical. PRP triggers an inflammatory and proliferative process that takes time. I tell my patients not to expect immediate results. The true benefits unfold over three to six months. The rehabilitation protocol must be tailored to this biological timeline.

Initial Rest Phase: Following the injection, a short period of relative rest allows the platelet clot to form and the initial inflammatory cascade to begin.
Protected Mobilization: We then gradually introduce a gentle range-of-motion exercise to prevent stiffness.
Progressive Loading: As the tissue begins to repair and remodel, we introduce progressive, controlled loading through specific exercises. This mechanical stimulation is essential for guiding the new collagen fibers to align properly, creating a strong, functional, and resilient tissue. This is a journey we guide the patient through, ensuring they do the right things at the right time to support the healing initiated by PRP.

Key Takeaways for Patients and Practitioners

My goal in this post is to emphasize that successful regenerative medicine requires a deep understanding of the product you deliver. We must move beyond generic labels and focus on the specifics.

Dose Matters: Think of PRP as a drug. A subtherapeutic dose will not work. We must aim for a specific dose tailored to the tissue and condition, with current evidence suggesting a target of >3.5 billion platelets for soft tissues and 5-10 billion platelets for knee OA.
Not All PRP Is Equal: The preparation system dictates the final product. Understand your system’s capabilities and limitations to ensure you can create a therapeutic dose.
It’s a Biological Process: Healing takes time. PRP initiates a cascade that unfolds over months. Patient education and managing expectations are key.
Integrative Care is Crucial: The best outcomes are achieved when PRP is combined with precision guidance, biomechanical correction, and a structured, biology-based rehabilitation program.

By embracing this evidence-based, detailed, and integrative approach, we can truly harness the remarkable healing potential of PRP and offer our patients lasting solutions for pain and dysfunction.

References

Bennell, K. L., Paterson, K. L., Metcalf, B. R., Duong, V., Emsley, R., Hinman, R. S., … & Harris, A. (2021). Effect of intra-articular platelet-rich plasma vs placebo on pain, function, and structural change in patients with knee osteoarthritis: The RESTORE randomized clinical trial. JAMA, 326(20), 2021-2030. https://doi.org/10.1001/jama.2021.19415

Everts, P., Onishi, K., Jayaram, P., Lana, J. F., & Mautner, K. (2020). Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. International Journal of Molecular Sciences, 21(20), 7794. https://doi.org/10.3390/ijms21207794

Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495-505. https://doi.org/10.1016/j.arthro.2015.08.005

Pak, J., Lee, J. H., & Lee, S. H. (2017). A novel protocol of platelet-rich plasma application for musculoskeletal medicine: a preliminary report. Journal of Prolotherapy, 9(1), e971-e979.

van der Weegen, W., van Drumpt, R., & de Sèze, P. B. (2016). The use of platelet rich plasma in knee osteoarthritis: a literature review and clinical interpretation. Bio-Orthopaedics Journal, 1(1).

May 20, 2026

PRP Therapy Overview for Non-Surgical Musculoskeletal Care

Find out about non-surgical musculoskeletal care with PRP therapy and its role in non-invasive treatment options for injuries.

Abstract

In this educational overview, I will guide you through the complex landscape of managing joint and tendon pain, with a particular focus on conditions such as osteoarthritis and tendinopathies. Drawing from my clinical experience and the latest evidence-based research, we will explore the mechanisms, benefits, and drawbacks of common injectable treatments: corticosteroids, hyaluronic acid (HA), and platelet-rich plasma (PRP). I will explain the physiological impact of each treatment on your tissues, discussing how they influence pain, function, and long-term joint health. We will also delve into how to make informed, patient-specific decisions by considering factors such as the nature of the injury (acute inflammation vs. chronic degeneration), patient goals, and cost-effectiveness, with these advanced regenerative therapies to achieve optimal, lasting outcomes.

Hello, I’m Dr. Jimenez. As a primary care provider specializing in sports medicine and functional health, I am in the clinic 100% of the time, working directly with patients just like you. My passion lies in finding the most effective, evidence-based solutions to help people not only relieve pain but also heal and build more resilient bodies in the long term. Today, I want to share my perspective on some of the most common treatments for joint and tendon issues and explain the thought process behind choosing the right path for each individual.

Why We Seek Alternatives to Traditional Approaches

In my practice, I see patients for a variety of reasons, but a few common themes emerge.

Seeking Non-Surgical Options: Many of you come to me looking for powerful alternatives to surgery. This is precisely why my specialty in non-operative sports medicine exists. You want to heal without the risks, downtime, and potential complications of an invasive procedure.
Desire for Faster Recovery: Whether you’re a competitive athlete or someone who wants to get back to playing with your grandchildren, you want to get better as quickly as possible.
Focus on Long-Term Tissue Health: This is perhaps the most crucial point. I can inject something to numb the pain temporarily, but are we actually helping the tissue heal? Or are we potentially causing harm down the line? My goal is not to provide a temporary fix that requires you to come back every few months for the rest of your life. Instead, we want to restore and strengthen damaged tissue and return you to your life with confidence and strength. This philosophy is at the core of regenerative and functional medicine.

Let’s consider a common scenario. A patient comes to me with a chronic tendon injury. A neurosurgeon sent them for evaluation. The problem isn’t just about pain; it’s about compromised tissue integrity. My objective is to do more than mask the symptoms. We want to change the tissue’s biology to promote a healthier, more robust state.

Understanding the Tools: Corticosteroids, HA, and PRP

When it comes to injectable treatments for joint and tendon pain, we have several tools at our disposal. It’s essential to understand what each one does, why we might use it, and what its limitations are.

Corticosteroids: The Double-Edged Sword

Corticosteroids (like cortisone) and powerful non-steroidal anti-inflammatory drugs (NSAIDs) like Toradol are well-known for providing rapid and potent pain relief. They work by aggressively shutting down the inflammatory process.

Mechanism: Corticosteroids are powerful anti-inflammatory agents. They suppress the immune response, reducing the swelling, warmth, and pain associated with inflammation.
The Downside: While they offer quick relief, this comes at a cost. Emerging research and extensive clinical observation have raised serious concerns about their long-term effects. A significant issue is chondrotoxicity, meaning they can be toxic to cartilage cells (chondrocytes). When we repeatedly inject steroids into a joint, we may be accelerating the very cartilage breakdown we are trying to prevent. Think of it this way: inflammation is part of the body’s natural healing signal. By completely silencing it, we might also be silencing the signals that call for repair and regeneration. The result is often a cycle of temporary relief followed by a return of pain, often worse than before, leading to more injections. Many patients I see have been on this “injection treadmill” and eventually end up needing surgery anyway.

Hyaluronic Acid (HA): The Joint Lubricant

Hyaluronic Acid (HA), also known as viscosupplementation, is a different approach. HA is a natural component of the synovial fluid that lubricates our joints.

Mechanism: In arthritic joints, the concentration and quality of HA are often diminished. Injecting a gel-like HA substance helps to restore the viscosity of the joint fluid. This provides better lubrication and shock absorption, improving the overall joint environment (homeostasis). It’s important to note that HA itself is not a direct anti-inflammatory in the classical sense, unlike a steroid. Its primary role is mechanical and supportive.
Application: I often think of it like this: I can inject a steroid into an “angry,” inflamed joint to calm it down, or I can add HA gel to improve the mechanics and reduce friction. In many cases, especially in an irritated joint, I might combine a short-term anti-inflammatory with HA to get the benefits of both—calming the fire and then improving the environment. In the United States, insurance typically covers HA injections only for knee osteoarthritis, but clinically, we see benefits in other joints, such as the shoulders, hips, and ankles. Patients often acquire the syringes from specialty pharmacies for these off-label applications.

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

This brings us to Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine.

Mechanism: PRP is a concentration of your own blood platelets, which we obtain through a simple blood draw and centrifugation process. Platelets are the body’s first responders to injury. They are packed with hundreds of growth factors and signaling proteins that orchestrate the entire healing cascade. When we inject PRP directly into an injured tendon or an arthritic joint, we deliver a powerful, concentrated dose of these natural healing signals. PRP doesn’t just mask pain; it works to:
- Modulate Inflammation: Unlike steroids, which obliterate inflammation, PRP modulates it. It helps transition the inflammatory state from a chronic, destructive process to an acute, regenerative one.
- Promote Tissue Healing: It stimulates the recruitment of stem cells to the area and encourages the formation of new blood vessels (angiogenesis) and new, healthy tissue (such as collagen in tendons or cartilage components in joints).
The Outcome: By using your body’s own biological software, PRP aims to fundamentally change the tissue environment, promoting true healing and creating a more durable, functional structure. This is how we move from managing symptoms to actually restoring tissue.

The Evidence: Comparing PRP, Steroids, and HA

The scientific community has been rigorously studying these treatments, and a clear picture is beginning to emerge.

PRP vs. Corticosteroids

A growing body of high-quality research shows that for many conditions, particularly osteoarthritis and tendinopathies, PRP is superior to corticosteroids. A systematic review and meta-analysis by Belk et al. (2021) found that, for knee osteoarthritis, patients treated with PRP experienced significantly greater improvements in pain and function than those who received corticosteroid injections, with benefits lasting much longer, often up to 12 months. Steroids, in contrast, typically provide relief for only a few weeks to a few months.

PRP vs. Hyaluronic Acid (HA)

Similarly, when PRP is compared to HA for knee osteoarthritis, the evidence favors PRP. Multiple studies, including a large-scale meta-analysis published in Arthroscopy, have demonstrated that PRP provides more significant and longer-lasting improvements in both pain scores and functional outcomes at 6 and 12 months post-injection (Laudy et al., 2015). While HA can be beneficial, PRP appears to offer a more profound and durable biological effect.

Summary of Evidence Table

Treatment	Mechanism of Action	Duration of Effect	Effect on Tissue	Best For
Corticosteroids	Potent anti-inflammatory	Short-term (1-12 weeks)	Potentially chondrotoxic (damaging to cartilage) with repeated use	Acute, severe inflammatory flare-ups when other options are not feasible
Hyaluronic Acid (HA)	Joint lubrication and shock absorption	Medium-term (up to 6 months)	Supportive, improves joint homeostasis	Mild to moderate osteoarthritis, especially when insurance covers it
Platelet-Rich Plasma (PRP)	Modulates inflammation, delivers growth factors to stimulate healing	Long-term (6-12+ months)	Regenerative, promotes healing and tissue repair	Chronic tendinopathies, mild to moderate osteoarthritis, long-term tissue health

Making the Right Choice: A Patient-Centered Approach

So, how do we decide which treatment is right for you? This is where a personalized, integrative approach becomes critical. There is no one-size-fits-all answer.

For Chronic Tendinopathy or Mild-to-Moderate Osteoarthritis: If you have a long-standing issue like tennis elbow, Achilles tendinopathy, or early-to-moderate joint arthritis without severe, acute inflammation, my first recommendation is almost always PRP. It addresses the underlying degenerative nature of the problem and offers the best chance for long-term healing and functional improvement. I try to avoid steroids in these cases to protect the long-term health of the tissue.
When Cost is a Major Factor: If PRP is not financially feasible and your insurance covers HA for knee osteoarthritis, it is a very reasonable and effective option that provides better long-term outcomes than steroids. With some insurance plans now dropping coverage for HA, the cost-benefit analysis is shifting. If you are paying out of pocket, the small additional cost of PRP may provide significantly more value, as it often requires fewer treatments over time.
For Acute, Severe Pain: There are times when a patient is in so much pain that their only goal is immediate relief. In these situations, judicious use of a corticosteroid injection can serve as a bridge. It can calm a severe inflammatory flare-up enough to allow the patient to engage in physical therapy and other restorative treatments. However, I always have a conversation with the patient: “This is a temporary solution to get you out of this crisis. Once the inflammation is under control, we need to address the underlying problem to prevent this from happening again.”

The Crucial Role of Integrative Chiropractic Care

Injectable therapies, even advanced ones like PRP, are only one piece of the puzzle. If we don’t address the underlying biomechanical issues that led to the tissue breakdown in the first place, the problem is likely to return. This is where integrative chiropractic care is essential.
As a Doctor of Chiropractic (DC) and a board-certified Family Nurse Practitioner, I see the body through a unique lens. Pain and degeneration in a joint or tendon are often symptoms of a deeper functional problem.

Restoring Biomechanics: A knee doesn’t exist in isolation. Its function is directly influenced by hip and ankle mobility, core stability, and pelvic alignment. Through chiropractic adjustments, soft tissue mobilization, and specific therapeutic exercises, we work to correct these imbalances. For example, if a patient has knee osteoarthritis, I will assess their hip mobility and foot mechanics. Often, hip stiffness or poor foot posture forces the knee to take on excessive rotational stress, accelerating wear and tear. By restoring normal movement patterns in the entire kinetic chain, we offload the damaged knee joint.
Enhancing the Effects of Regenerative Injections: Performing a PRP injection without correcting the faulty mechanics is like patching a tire without fixing the alignment that caused it to wear out unevenly. The patch won’t last. Chiropractic care creates an optimal biomechanical environment for the regenerative process to succeed. By improving joint alignment and muscle function, we ensure that the newly forming tissue is not immediately subjected to the same stresses that caused the initial injury. This synergy between advanced regenerative injections and foundational chiropractic care is the key to achieving durable, long-term success.

At my clinic, a comprehensive treatment plan for a patient with knee osteoarthritis might involve a PRP injection to stimulate cartilage repair, combined with a targeted program of chiropractic adjustments to the lumbar spine and pelvis, mobilizations for the hip and ankle, and a tailored exercise regimen to strengthen the gluteal muscles and improve neuromuscular control. This holistic approach ensures we are treating not just the site of pain, but the entire system.

Final Thoughts

The world of medicine is moving away from simply managing symptoms and toward restoring function and promoting true healing. When we talk about treating joint and tendon pain, we have to consider the long-term implications of our choices.

Steroids have their place for short-term crisis management, but pose a risk to long-term tissue health.
Hyaluronic Acid is a safe and effective lubricant, offering a good supportive option for osteoarthritis.
Platelet-Rich Plasma (PRP) stands out as a superior treatment for promoting true tissue healing and offering lasting functional improvement, supported by robust scientific evidence.

Ultimately, the best approach is personalized to you—your specific condition, your goals, and your body’s unique needs. By combining advanced regenerative therapies like PRP with the foundational principles of integrative chiropractic care, we can go beyond temporary fixes and help you move toward lasting health, durability, and a full return to the life you love.

References

Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49(9), 2498–2510. https://doi.org/10.1177/0363546520909397
Laudy, A. B. M., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–665. https://doi.org/10.1136/bjsports-2014-094036

SEO Tags: Joint Pain, Osteoarthritis Treatment, PRP Therapy, Platelet-Rich Plasma, Hyaluronic Acid, Cortisone Injections, Regenerative Medicine, Integrative Chiropractic Care, Sports Medicine, Tendinopathy, Knee Pain, Non-Surgical Treatment, Dr. Alexander Jimenez, El Paso, TX, Functional Medicine

May 19, 2026

FDA Clarifications for PRP and Chiropractic Practice

Abstract

In this educational post, I share clear, first-person guidance on platelet-rich plasma (PRP) therapy—what it is, how the FDA views it, and how to talk about it with patients who ask about approval, safety, and consent. I explain why PRP devices can be FDA-cleared while the PRP itself is not FDA-approved, and why that distinction matters clinically and ethically. I also walk through practical ways to optimize PRP quality, including evidence-informed recommendations on exercise, diet, and NSAID use, and I discuss what we do and do not yet know from current research. Finally, I outline how integrative chiropractic care fits into PRP treatment, detailing biomechanics, neuromuscular coordination, fascial dynamics, and nociceptive modulation, and I provide stepwise protocols that I use in practice. My goal is to give clinicians and patients a structured, research-grounded path from confusion to confidence.

Introduction: Why Patients Ask About PRP Approval and Why Clinicians Need Clarity

When patients ask me whether PRP is “FDA approved,” they are really asking, “Is this safe?” Is it legitimate?” Does it work? As a clinician working across musculoskeletal medicine and integrative chiropractic care, I’ve learned that the best results come from blending transparent communication with rigorously applied, evidence-based protocols. I want to clarify the regulatory language and connect it to what we can do today to improve clinic outcomes.

I’ll start by clarifying the difference between FDA device clearance and drug approval. Then I’ll outline practical steps to enhance PRP quality, including timing of NSAIDs, diet strategies, and targeted high-intensity exercise. I’ll also share how integrative chiropractic care and functional rehabilitation synergize with PRP, based on physiological mechanisms and clinical observations I’ve discussed widely in my practice and professional communications.

FDA Status of PRP: What “Cleared” Means and Why PRP Itself Is Not Approved

Here’s the core regulatory truth: PRP kits and centrifuges—medical devices used to prepare platelet-rich plasma—can be and often are FDA 510(k)-cleared. This means the device is substantially equivalent to a legally marketed device and is cleared for specific indications, such as the separation of blood components. By contrast, the PRP itself—your plasma enriched with platelets—is an autologous biologic, not a manufactured drug. Under current rules, PRP is not “FDA approved” as a drug to treat a specific disease (like knee osteoarthritis), because it doesn’t fit the drug pathway that requires large-scale, expensive clinical trials and a manufacturer-controlled product.

Key points I share with patients:

Devices used to prepare PRP are often FDA 510(k)-cleared for blood processing.
PRP, as a biologic derived from the patient’s own blood, is not a drug and therefore does not undergo FDA drug approval.
The FDA does not “approve procedures.” It regulates products (drugs, devices, biologics) and claims. Procedures—like autologous PRP injection—are governed by the standard of care, state scope of practice, and ethical informed consent.
Clinically, we rely on peer-reviewed evidence demonstrating the benefits of PRP for certain musculoskeletal conditions, while being honest about variability and the need for individualized protocols.

Why this matters:

Patients sometimes assume a lack of “approval” means experimental. I clarify that “not FDA approved” for a biologic like PRP is a category distinction, not a verdict on quality or usefulness. We build confidence by presenting the data and setting expectations.

Informed Consent and Ethical Language: How I Explain PRP Status

In consent discussions, I use language that respects both science and patient autonomy:

I state that the device used is FDA-cleared for blood component preparation.
I explain that PRP injections are a procedure using the patient’s own blood, and the FDA does not approve procedures.
I review the evidence base: what conditions PRP has been shown to help, where results are mixed, and what factors influence outcomes.
I discuss risks, benefits, alternatives (including conservative care, physical therapy, and integrative chiropractic strategies), and the inherent uncertainty of biologic therapies.

Clinically, this avoids the misleading frame of “waiting for FDA approval.” An autologous PRP product is not a drug, and there is no drug-approval pathway for it. Instead, I emphasize the quality of evidence, the care team’s experience, and the patient’s goals.

Optimizing PRP Quality: Exercise, Diet, and NSAIDs

One of the most practical parts of PRP care is preparing the patient’s physiology for the blood draw and injection. Several modifiable factors can influence platelet count, platelet activation, and growth factor release.

High-Intensity Exercise Before Draw

What we know: Short-term high-intensity exercise can transiently increase platelet count and alter platelet activation dynamics, likely via catecholamines (epinephrine, norepinephrine), hemoconcentration, and shear stress–mediated endothelial interactions. Acute bouts (e.g., 10–20 minutes of cycling intervals) may nudge platelet counts and potentially the concentration yields of PRP during processing.
Mechanisms: Intense exercise drives sympathetic activation, raises circulating catecholamines, mobilizes platelets from the splenic reservoir, and increases shear stress, which can prime platelets. It also activates the AMPK and PGC-1α pathways in muscle, thereby shaping an anti-inflammatory milieu and beneficial epigenetic signatures in immune cells.
Practical protocol: I often have patients perform a 15–20-minute high-intensity interval bike session (if medically appropriate) shortly before a blood draw. We monitor vitals and avoid overexertion. For those unable to do intervals, brisk cycling or supervised calisthenics (e.g., jumping jacks, step-ups) can be used as alternatives.
Why I use it: The potential to increase platelet availability and enhance growth factor profiles is attractive, with low risk when supervised. While individual responses vary, the cost-benefit is favorable.

NSAIDs Before and After PRP

What we know: NSAIDs can inhibit cyclooxygenase (COX-1/COX-2) pathways, reducing thromboxane A2 synthesis, which is pivotal for platelet aggregation. In vitro, NSAIDs can disaggregate platelets and blunt activation-dependent granule release (alpha and dense granules), potentially diminishing the orchestrated regenerative signaling PRP relies upon.
Evidence is mixed regarding clinical impact. However, given PRP’s mechanism—relying on controlled platelet activation, fibrin scaffold formation, and paracrine signaling (PDGF, TGF-β, VEGF)—I recommend caution.
Practical protocol: I advise patients to avoid NSAIDs 10–14 days pre-procedure and for a similar window post-procedure unless medically necessary. We substitute with acetaminophen for analgesia and consider topical NSAIDs later if needed, depending on the anatomical site and vascular exposure.
Why I use it: It aligns with platelet physiology and avoids dampening the critical aggregation and growth factor release that PRP is intended to elicit.

Anti-Inflammatory Diet and Hydration

What we know: Nutritional status influences systemic inflammation, endothelial function, and platelet reactivity. A diet rich in omega-3 fatty acids, polyphenols (berries, green tea), and magnesium supports a balanced inflammatory tone and vascular health. Adequate hydration improves plasma volume, facilitating venipuncture and consistent processing.
Mechanisms: Omega-3s (EPA/DHA) can integrate into platelet membranes, modulating eicosanoid profiles and dampening excessive aggregation. Polyphenols influence NF-κB signaling and antioxidant capacity. Stable insulin dynamics reduce pro-inflammatory cytokines (IL-6, TNF-α).
Practical protocol: In the week leading up to PRP, I recommend:
- Emphasize omega-3-rich foods (wild-caught fish, flax, chia) or supplementation if appropriate.
- Increase colorful vegetables and polyphenol-rich fruits.
- Maintain adequate hydration; limit alcohol.
- Avoid ultra-processed foods and excessive sugar to minimize postprandial inflammation.
Why I use it: It’s low-risk, supports vascular and immune function, and aligns with regenerative goals.

Blood Flow Restriction (BFR) and Pre-Draw Conditioning

What we know: Emerging data on blood flow restriction training suggest anabolic signaling via mTOR, local hypoxia-inducible factors (HIF-1α), and increased growth hormone responses. Direct evidence on improving PRP yields is limited and mixed. Some centers incorporate brief cycling or calisthenics. A few studies suggest that BFR may modulate local platelet dynamics, but consistency has not been established.
Practical stance: I consider BFR as an adjunct for rehabilitation phases post-PRP rather than a pre-draw tool. If used pre-draw, it should be clinician-supervised and patient-specific.
Why I use it selectively: The uncertainty on PRP yield benefits doesn’t outweigh the clear rehab benefits of BFR for strength gains at low loads, which is valuable after injection.

What Counts Most: Dose, Product, and Indication

In my experience, the “core principles” are:

Using the right PRP preparation (leukocyte-poor vs. leukocyte-rich) matched to the condition.
Achieving the proper platelet concentration (often 3–7x baseline) without reaching the inhibitory threshold, where excessive concentration can paradoxically reduce efficacy.
Matching the indication: Tendinopathies and certain joint conditions respond differently. Accurate diagnosis, imaging guidance, and tissue targeting matter more than marginal gains from pre-draw hacks.

Physiological Underpinnings: Why PRP Works and Where It Struggles

PRP’s promise rests on the biological choreography of platelet activation and paracrine signaling:

Upon activation, platelets release PDGF, TGF-β, VEGF, IGF-1, and FGF, orchestrating chemotaxis, angiogenesis, fibroblast proliferation, and extracellular matrix remodeling.
The fibrin scaffold forms a localized matrix for cell migration and sustained growth factor presentation.
Leukocyte content modulates cytokine milieu. In tendinopathy, excess leukocytes may increase catabolic cytokines; in some wounds, leukocytes assist antimicrobial defense and clean-up. This is why product phenotyping matters.

Where PRP struggles:

In advanced osteoarthritis with severe cartilage loss and bone marrow lesions, PRP’s signals may be insufficient without concurrent biomechanical unloading and metabolic support.
Poor systemic health—uncontrolled diabetes, high systemic inflammation, or active smoking—can blunt regenerative signaling.

Integrative Chiropractic Care: Synergy With PRP for Musculoskeletal Healing

This is where integrative chiropractic care plays a crucial role. PRP sets the biochemical stage; chiropractic and functional rehabilitation shape the mechanical and neuromuscular context in which tissues attempt to heal.

Key domains I harmonize:

Biomechanical Alignment and Load Distribution
- Why it matters: Joint mechanics determine stress concentration zones. Malalignment increases shear forces, aggravates tendons and articular cartilage, and perpetuates nociceptive signaling.
- Protocols: After PRP injections, I use gentle segmental mobilization and targeted soft-tissue release to normalize joint play and reduce fascial adhesions. As pain reduces, we transition to closed-chain stability exercises to retrain load-bearing patterns.
- Physiological rationale: By reducing aberrant shear and restoring arthrokinematics, we lower catabolic signals (MMPs) and allow PRP-mediated anabolism to proceed.
Fascial Dynamics and Neuromuscular Coordination
- Why it matters: The fascia is richly innervated and responsive to tension. Dysregulated fascial tone contributes to pain and dysfunctional movement patterns. PRP benefits when we reduce myofascial guarding and improve proprioception.
- Protocols: I apply instrument-assisted myofascial release, PNF stretching, and breath-coordinated mobilizations. We integrate sensorimotor retraining (balance work, reactive drills) to refine neuromuscular timing.
- Physiological rationale: Improved afferent input from fascia and joint receptors recalibrates motor outputs via the spinal cord and cerebellum, reducing overuse of compensatory muscles. Better coordination reduces re-injury and supports collagen remodeling directed by PRP signals.
Nociceptive Modulation and Central Sensitization
- Why it matters: Persistent pain can upregulate central sensitization, magnifying nociception. PRP’s local effects need systemic support to downshift neural gain.
- Protocols: Gentle manual therapy, graded exposure, and breathing techniques (slow diaphragmatic breathing to enhance vagal tone) help reduce sympathetic overdrive. Sleep optimization and stress modulation are included.
- Physiological rationale: Enhancing parasympathetic activity reduces inflammatory cytokine release via the cholinergic anti-inflammatory pathway, improving recovery conditions.
Strength and Conditioning With Joint Protection
- Why it matters: Improved tissue quality is wasted without robust, well-coordinated musculature. Strength protects joints by distributing loads and stabilizing movement.
- Protocols: We progress from isometrics to eccentrics, then to controlled concentrics. For tendinopathy, eccentric loading programs remain foundational. If appropriate, BFR training enables hypertrophy at low loads during early phases.
- Physiological rationale: Mechanical loading stimulates tenocyte and chondrocyte anabolic activity via integrin signaling and mechanotransduction pathways (FAK, MAPK), synergizing with PRP’s growth factor environment.

Stepwise Integrated Protocol: From Consultation to Recovery

I use a structured approach that patients appreciate because it turns complexity into clarity:

Step 1: Medical and Functional Assessment
- Comprehensive history, medications, NSAID review, and comorbidities.
- Functional movement screening and targeted imaging, if needed.
- Discussion of goals and setting realistic expectations.
Step 2: Pre-PRP Preparation
- NSAIDs: Hold for 10–14 days pre-procedure if possible.
- Nutrition: Emphasize omega-3s, polyphenols, and hydration.
- Exercise: 15–20 minutes high-intensity intervals prior to blood draw (if safe).
- Sleep and stress: Reinforce sleep hygiene to optimize hormonal and immune balance.
Step 3: PRP Collection and Processing
- Use an FDA 510(k)-cleared device appropriate for the indication.
- Decide on leukocyte-poor vs. leukocyte-rich PRP based on target tissue and current evidence.
- Ultrasound guidance for precise placement when indicated.
Step 4: Immediate Post-Injection Care
- Avoid NSAIDs for another 10–14 days; use acetaminophen judiciously.
- Gentle mobility, protection of the injected area, and no aggressive stretching in the acute phase.
- Education on expected soreness and timelines.
Step 5: Integrative Chiropractic and Rehab Progression
- Week 1–2: Pain-modulated manual therapy, gentle mobilization, and isometrics.
- Week 3–6: Progressive eccentrics and proprioceptive training; address gait, posture, and ergonomic loads.
- Week 6+: Strength, power (if appropriate), and return-to-sport mechanics.
- Consider BFR selectively for low-load hypertrophy.
Step 6: Monitoring and Outcomes
- Reassess pain, function, and movement patterns at set intervals.
- Adjust programming based on tissue response and patient goals.
- Consider repeat PRP only when clinically justified and after biomechanical deficits are addressed.

Clinical Observations From My Practice

Across my work in El Paso and in conversations shared through my clinic’s educational platforms, I consistently observe:

Patients who follow NSAID guidance, nutrition support, and pre-draw exercise tend to have more predictable recoveries.
Matching the PRP product phenotype to the indication greatly influences outcomes. For example, leukocyte-poor PRP is often suitable for intra-articular injections, while some tendon cases benefit from a carefully titrated leukocyte content.
Integrative chiropractic interventions lower re-injury rates by correcting movement faults and fascial restrictions that would otherwise undermine PRP’s benefits.
Stress, sleep deprivation, and deconditioning are silent saboteurs. Coaching patients on these areas is as important as the injection itself.

What We Still Don’t Know—And How We Manage Uncertainty

The field continues to evolve:

The precise weighting of factors such as NSAID timing, specific exercise protocols, and BFR effects on PRP yield remains under investigation.
Ideal dosing regimens (single vs. series of injections), optimal intervals, and cross-comparisons with other orthobiologics (BMAC, microfragmented adipose tissue) are active areas of research.
Insurance coverage remains inconsistent, and large-scale trials are costly, which slows standardization.

How I navigate this:

I rely on longitudinal patient tracking, functional metrics, and imaging when needed.
I apply the precautionary principle where physiology suggests potential interference (e.g., NSAIDs).
I tailor protocols to patient-specific biomechanics and goals, integrating chiropractic care to create a favorable mechanical environment for biologic healing.

Communicating With Patients: Clear, Confident, and Compassionate

When patients ask, “Is PRP FDA approved?” I answer:

The device we use to prepare your PRP is FDA-cleared for that purpose.
Your PRP is your blood product; it is not a drug, and the FDA does not approve procedures.
We base our recommendation on studies showing benefits for your condition, our clinical experience, and a protocol designed to maximize your body’s healing response.

When they ask: “Is this experimental?”

I explain that while PRP is not “approved” like a drug, it is widely used, supported by modern studies for specific indications, and integrated into an evidence-informed care plan. We will review risks, benefits, and alternatives so you can make an informed decision.

Conclusion: A Practical, Ethical Path Forward for PRP

PRP is a powerful tool when used thoughtfully. By clarifying the distinction between FDA clearance and approval, optimizing platelet physiology through exercise, diet, and NSAID management, and embedding PRP within a comprehensive integrative chiropractic plan, we provide patients the best chance for meaningful recovery. While some variables remain under study, our responsibility is to apply the strongest available evidence, monitor outcomes, and continually refine care.

I invite patients and clinicians to adopt this structured approach and engage with our team as we continue to advance protocols grounded in science and compassionate care.

References

U.S. Food and Drug Administration: 510(k) Premarket Notification (FDA, n.d.).
American Academy of Orthopaedic Surgeons: Platelet-Rich Plasma (PRP) (AAOS, n.d.).
Everts, P. A., et al. Platelet-rich plasma and platelet lysate: review of their mechanisms of action in tissue repair and regeneration (Everts et al., 2017).
Chaudhury, S., et al. Autologous blood injections and platelet-rich plasma for tendinopathy (Chaudhury et al., 2011).
O’Connell, B., et al. The role of exercise on platelet function and hemostasis (O’Connell et al., 2015).
Hawkins, D., et al. Nonsteroidal anti-inflammatory drugs and platelet function (Hawkins et al., 2004).
Pearson, T., et al. Omega-3 fatty acids and platelet aggregation (Pearson et al., 2005).
Scott, A., et al. Eccentric training for tendinopathy: mechanotransduction pathways (Scott et al., 2009).
Hughes, L., et al. Blood flow restriction training: mechanisms and applications (Hughes et al., 2017).

May 18, 2026

PRP Therapy for Pain Relief, Healing, and Recovery

Abstract

Welcome to an in-depth exploration of Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine. We will delve into the very essence of platelets, exploring the powerful growth factors, cytokines, and other bioactive molecules they release. Drawing from the latest findings of leading researchers, we’ll examine how these components orchestrate the body’s natural healing and anti-inflammatory processes. I will explain the critical concept of PRP dosing, the importance of different platelet types, and how specific growth factors such as PDGF, TGF-β, and FGF contribute to tissue repair and regeneration. Finally, we’ll connect these principles to clinical practice, showing how integrative chiropractic care can be synergistically combined with PRP therapy to optimize patient outcomes, reduce pain, and restore function by addressing both the biochemical and biomechanical aspects of healing.

The Cellular Orchestra: Understanding the Power Within Your Blood

For over a decade, my clinical practice has been deeply rooted in the principles of functional and regenerative medicine. A recurring theme in helping patients overcome chronic pain and injury is the quest to harness the body’s innate ability to heal itself. One of the most powerful tools we have in this endeavor is Platelet-Rich Plasma (PRP). While many have heard the term, the true depth of what’s happening at a cellular level is often misunderstood. Today, I want to take you on a journey into the microscopic world of PRP, moving beyond the buzzwords to appreciate the sophisticated biological symphony it conducts.

When we talk about PRP, we’re focusing on concentrating a specific component of your blood: the platelets, also known as thrombocytes. While red blood cells and white blood cells play their own roles, it’s the platelets that act as the master conductors of tissue repair. The therapeutic magic of PRP lies in the wealth of bioactive components housed within these tiny cell fragments. These include:

Growth Factors: Proteins that signal cells to grow, proliferate, and differentiate.
Cytokines: Small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells.
Anti-inflammatory Molecules: Compounds that help modulate and resolve inflammation, which is a key barrier to healing.

The fundamental idea is that by concentrating these platelets, we can deliver a supraphysiological dose of these healing molecules directly to an injured area, amplifying the body’s natural repair signals and creating an optimal environment for regeneration.

Inside the Platelet: A Treasure Trove of Healing Granules

To truly grasp how PRP works, we need to look inside the platelet itself. Think of a platelet as a microscopic delivery vehicle packed with different types of cargo containers, or granules. The main therapeutic benefit we seek comes from the contents of these granules, which are released upon activation at the site of injury.

The three primary types of granules are:

Alpha Granules: These are the most abundant and arguably the most important for regeneration. Each platelet contains about 50 to 80 alpha granules, which are filled with a vast array of powerful growth factors. When a platelet is activated—for instance, by contact with exposed collagen in damaged tissue—it undergoes a process called degranulation, releasing growth factors into the surrounding environment. This is the primary event that initiates the healing cascade.
Dense Granules (or Delta Granules): These granules contain small molecules, including ADP, ATP, serotonin, and calcium. Their role is to amplify the healing response. They enhance platelet aggregation (helping form a stable scaffold) and vasoconstriction (controlling bleeding), and they also modulate the local immune response.
Lysosomes: These act as the cleanup crew. They release enzymes that help break down and remove damaged tissue and cellular debris from the injury site. This process, known as enzymatic debridement, clears the way for new, healthy tissue to form and also contributes to antimicrobial defense.

Recent research, including studies on platelet biology, highlights that over 280 distinct proteins are involved in this process, underscoring the incredible complexity of this “orchestra” of molecules working in concert (Golebiewska & Poole, 2015).

The Significance of Platelet Quality and “Dosing”

A critical concept that has emerged from evidence-based research is that not all PRP is created equal. The effectiveness of a treatment depends heavily on both the concentration and quality of the platelets. This is where the idea of PRP dosing becomes paramount. Simply put, the more functional platelets we can deliver to a target tissue, the greater the concentration of bioactive molecules we release, and potentially, the more robust the healing response.

Furthermore, we are learning about the importance of reticulated platelets. These are essentially “younger,” more robust platelets, recently released from the bone marrow (typically within the last 24-72 hours). They are denser and contain more alpha granules than their older counterparts. This means they are packed with more growth factors and have a greater regenerative potential. In our clinical processing, we use advanced techniques to preferentially harvest these denser, more potent reticulated platelets, ensuring that the PRP we inject is of the highest possible quality and biological activity.

The Key Players: A Closer Look at Essential Growth Factors

While hundreds of proteins are released, a few key growth factors are the primary drivers of the regenerative effects seen with PRP. Understanding their specific roles helps us appreciate why this therapy is so effective for a range of musculoskeletal conditions.

Platelet-Derived Growth Factor (PDGF)

As its name implies, PDGF was first discovered in platelets, but it’s also produced by other cells involved in healing. Think of PDGF as the “first responder” or the primary chemoattractant. It sends out a powerful signal that calls other crucial healing cells to the site of injury. Most importantly, it recruits Mesenchymal Stem Cells (MSCs)—the body’s own master repair cells—to the area. While PRP itself does not contain stem cells, it potently signals the body’s resident stem cells to migrate to the site, proliferate (make copies of themselves), and differentiate into the specific cell types needed for repair (e.g., cartilage, tendon, or bone cells). The PDGF-BB isoform is recognized as the most biologically active and is a major focus of current research for its potent role in initiating this cascade.

Transforming Growth Factor-Beta (TGF-β)

TGF-β is a master regulator of tissue regeneration. Its primary functions include:

Stimulating Collagen Synthesis: It powerfully enhances the production of type I collagen, the fundamental building block of tendons, ligaments, and the matrix of our bones and cartilage. This is essential for rebuilding the structural integrity of injured tissue.
Promoting Angiogenesis: the formation of new blood vessels. A healthy blood supply is critical for delivering oxygen and nutrients to the healing tissue and removing waste products.
Coordinating with Other Growth Factors: TGF-β works synergistically with PDGF to enhance endothelial cell proliferation and capillary sprouting, leading to a robust network of new blood vessels (neovascularization) that supports long-term tissue health.

The effect of PRP on angiogenesis is dose-dependent. Studies, such as those published in the Journal of Orthopedic Research, suggest that a platelet concentration of approximately 1.5 billion platelets per milliliter is required to achieve a significant pro-angiogenic effect (Mazzocca et al., 2012). This underscores the importance of precise processing and quantification to achieve optimal clinical results.

Fibroblast Growth Factor (FGF)

FGF is one of the most potent mitogens released by platelets, meaning it is exceptionally effective at stimulating cell division. It acts on a wide variety of cell types, including MSCs, chondrocytes (cartilage cells), and osteoblasts (bone-forming cells). By promoting the rapid proliferation of these essential repair cells, FGF accelerates tissue regeneration.

The Anti-Inflammatory Power of PRP

Chronic, unresolved inflammation is a major culprit behind persistent pain and tissue degradation, especially in conditions like osteoarthritis. While PRP initiates an acute, controlled inflammatory response to jumpstart healing, one of its most profound long-term benefits is its ability to modulate and resolve chronic inflammation.

This is achieved through several mechanisms:

Leukocyte Interaction: The concentrated platelets in PRP interact with white blood cells (leukocytes) at the injury site. This interaction can shift the behavior of these immune cells, prompting them to release anti-inflammatory cytokines like IL-10 and IL-4, which actively suppress chronic inflammation.
Macrophage Polarization: PRP can influence macrophage behavior, a type of white blood cell. It promotes a shift from the pro-inflammatory (M1) phenotype to an anti-inflammatory and pro-reparative (M2) phenotype. M2 macrophages are critical for cleaning up debris, resolving inflammation, and secreting factors that promote tissue remodeling and regeneration.
Chemokine Secretion: Platelets release chemokines that not only recruit healing cells but also act as survival factors for monocytes, preventing their premature death and promoting their differentiation into beneficial M2 macrophages.

In essence, PRP acts as a biological “reset button,” transforming a chronically inflamed, degenerative environment into one that is actively anti-inflammatory and pro-regenerative.

Integrating Chiropractic Care for a Holistic Healing Approach

As a Doctor of Chiropractic, I view the body through both biomechanical and biochemical lenses. A successful outcome depends on addressing both the “parts” and the “system.” This is where the synergy between PRP therapy and integrative chiropractic care becomes so powerful.

Imagine a patient with chronic knee osteoarthritis. The PRP injection will address the biochemical problem inside the joint—reducing inflammation, signaling cartilage repair, and improving the quality of the synovial fluid. However, if the patient’s knee pain is also caused or exacerbated by poor biomechanics—such as a misaligned pelvis, muscle imbalances in the leg, or improper gait—the joint will remain under abnormal stress. This persistent mechanical strain can hinder the regenerative process initiated by the PRP and lead to a recurrence of symptoms.

This is why our integrative approach includes:

Chiropractic Adjustments: We perform precise adjustments to the spine and extremities to restore proper alignment and mobility of the joints. Correcting pelvic alignment, for example, can ensure that forces are distributed evenly through the knees, reducing abnormal wear and tear.
Myofascial Release and Soft Tissue Work: We address muscle imbalances, trigger points, and fascial restrictions that contribute to faulty movement patterns. This ensures that the muscles supporting the joint are functioning optimally.
Customized Rehabilitation: We design targeted exercise programs to strengthen weak muscles, stretch tight ones, and retrain proper movement patterns (neuromuscular re-education). This stabilizes the joint and protects it from future injury.

By combining the powerful biochemical signaling of PRP with the essential biomechanical corrections of chiropractic care, we create a comprehensive healing environment. The PRP rebuilds tissue from the inside out, while chiropractic care ensures the entire musculoskeletal system functions correctly to support and protect the newly regenerated tissue. In my clinical experience, this holistic strategy is the key to achieving durable, long-term pain relief and true restoration of function for my patients.

References

Golebiewska, E. M., & Poole, A. W. (2015). Platelet secretion: From dogma to discovery. Platelets, 26(2), 95–104. https://doi.org/10.3109/09537104.2014.999602
Mazzocca, A. D., McCarthy, M. B. R., Chowaniec, D. M., Cote, M. P., Romeo, A. A., Bradley, J. P., Arciero, R. A., & Beitzel, K. (2012). The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Journal of Orthopaedic Research, 30(11), 1711–1719. https://doi.org/10.1002/jor.22074

May 8, 2026

PRP Injections and Their Benefits for Osteoarthritis

Discover the potential of PRP injections for osteoarthritis treatment and its role in promoting healing and reducing inflammation.

Abstract

As a clinician dedicated to integrative and evidence-based care, I frequently encounter patients suffering from knee osteoarthritis (OA) who are seeking relief. The decision on which injectable treatment to use can be complex, involving a delicate balance of providing rapid pain relief, ensuring long-term joint health, and considering the patient’s individual needs and goals. In this educational post, I will guide you through the latest research on common intra-articular injections for knee OA. We will begin by examining the role and significant risks of corticosteroids, exploring why the medical community is moving toward alternatives. I will then introduce ketorolac, an NSAID injection, as a safer, fast-acting alternative for acute flares. We’ll delve into the science of hyaluronic acid (HA), or viscosupplementation, evaluating its potential for longer-term benefits and its current standing in clinical guidelines. Finally, we will explore the exciting and robust evidence supporting Platelet-Rich Plasma (PRP) as a treatment that not only manages pain but also shows promise as a disease-modifying therapy capable of delaying the need for surgery. Throughout this discussion, I will integrate my clinical observations and emphasize how an integrative chiropractic approach, focusing on biomechanics and holistic patient care, complements these advanced treatments to optimize outcomes for our patients.

Hello, I’m Dr. Alexander Jimenez. With my extensive background in chiropractic and functional medicine, holding titles such as DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, my practice is rooted in a deep commitment to providing integrative care grounded in the latest scientific evidence. Today, I want to take you on a journey through the landscape of injectable treatments for knee osteoarthritis, a condition I see daily in my clinic. We’ll examine what the research tells us and how we can make the best choices for our patients.

Let’s begin with a common clinical scenario to frame our discussion.

A Common Clinical Scenario: The Acute Knee OA Flare

Imagine a 60-year-old woman who comes into my office with an acute flare-up of her right knee pain. She was diagnosed with mild osteoarthritis two years prior and had managed it well with physical therapy and weight loss. She remains quite active, but this current flare started after a bit more walking than usual. There was no specific injury or trauma. She presents with mild swelling, and her pain is most pronounced when using stairs. Her son’s wedding is just a week away, and she is understandably anxious, requesting an injection to improve her pain and mobility for the event.

On examination, she has a mild antalgic gait (walking with a limp to avoid pain), tenderness along the medial joint line, and a small effusion (swelling within the joint). Her X-rays confirm tricompartmental osteoarthritis with a Kellgren-Lawrence (K-L) grade of 2, which is considered mild to moderate.

So, we have a patient with an acute OA flare, no history of prior injections, and a significant life event approaching. What is the best way to help her? The most conventional response in many practices would be an intra-articular corticosteroid injection. But is that the right answer? My goal today is not to give you a single “correct” answer but to arm you with the evidence so you can make an informed decision, one that aligns with the principles of modern, evidence-based care.

The Double-Edged Sword of Corticosteroid Injections

Why Corticosteroids are so Common

There’s a clear reason why corticosteroids have been the go-to for decades. The primary driver of pain and swelling in an OA flare is synovial inflammation. Corticosteroids are potent anti-inflammatory agents. They work by:

Suppressing the infiltration of leukocytes (white blood cells) into the joint.
Decreasing the activity of local immune cells within the synovium (the soft tissue lining the joint).
Downregulating the expression of genes involved in the inflammatory cascade.

This powerful anti-inflammatory effect leads to decreased synovial membrane inflammation and a reduction in the effusion. The result is rapid pain relief, typically occurring within three to seven days. For our patient with the wedding next week, this timeline is very appealing. While oral NSAIDs or steroids could be considered, they carry significant systemic risks that an injection helps to minimize.

The Mounting Evidence Against Corticosteroids

Despite the short-term benefits, a growing body of evidence urges caution. There is significant concern for chondrotoxicity, meaning the substance is toxic to cartilage cells. Preclinical studies have provided robust evidence that steroids exert dose-dependent deleterious effects on cartilage morphology, histology, and viability. Simply put, the higher the dose of the steroid, the more damage it can cause to the cartilage. Among the different types, dexamethasone and triamcinolone appear to be the least toxic, but the risk remains.

This isn’t just a finding in lab studies. High-level clinical trials support these concerns. A pivotal study published in JAMA in 2017 was a two-year, randomized, placebo-controlled trial comparing injections of triamcinolone to saline in patients with knee OA (McAlindon et al., 2017). Patients received an injection every 12 weeks. The findings were startling:

There was no significant difference in pain relief between the steroid group and the placebo (saline) group over the two years.
The group receiving repeated steroid injections experienced significantly greater cartilage volume loss compared to the placebo group.

Another powerful retrospective review of over 49,000 patients, published in 2019, found that patients who received even one to three steroid injections (for various hip or knee conditions, not just OA) had a twofold greater risk of needing a knee replacement at the five-year mark (Kompel et al., 2019). The study also revealed a dose-dependent relationship: the risk of total knee arthroplasty (TKA) increased with each subsequent injection.

In my clinical practice at ChiroMed, I’ve observed this pattern. Patients who have received multiple steroid injections over the years often present with more advanced degenerative changes on their imaging than their symptom history might suggest. This is why there is a strong call within the medical community to find safer alternatives. While a single, first-time injection for an acute flare might seem reasonable, we must ask ourselves if we are sacrificing long-term joint health for short-term relief.

Ketorolac: A Safer, Fast-Acting Alternative for Knee Flares

If we want to avoid the chondrotoxic effects of steroids but still provide rapid relief for a patient like the one we discussed, where do we turn? I want to present an excellent alternative: ketorolac.

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that can be injected directly into the joint. Its mechanism of action is different from and safer than corticosteroids:

As a COX-1 and COX-2 inhibitor, it blocks prostaglandin production, which is a key mediator of inflammation and pain sensitization.
Delivering it locally via injection achieves a high concentration in the synovial fluid, providing potent anti-inflammatory effects with minimal systemic exposure compared with oral NSAIDs.
Crucially, ketorolac provides anti-inflammatory and analgesic effects without the immunosuppressive and gene-expression-altering effects of steroids.

Most importantly, preclinical models have not shown the deleterious structural effects on cartilage that we see with steroids. Its onset of action is similar, within a few days, and its efficacy often lasts for a few months.

A 2021 systematic review and meta-analysis confirmed that, for knee and hip OA, an intra-articular ketorolac injection provides pain and functional improvements similar to those of corticosteroids from one week to three months post-injection, with minimal adverse events (Saltzman et al., 2021). Our own research has echoed these findings. In a study we conducted on hip pathologies, including OA, we found a trend toward greater pain improvement in the ketorolac group, which was statistically significant for the OA patients. The onset of relief was rapid (around 3 days for ketorolac), and the duration was comparable to that of steroids.

Therefore, ketorolac stands out as a fantastic steroid-sparing option. It addresses the same goal—rapid relief from an inflammatory flare—without the known cartilage toxicity. However, we must still be cautious and avoid its use in patients with contraindications to NSAIDs, such as a history of gastrointestinal ulcers, severe cardiac or kidney disease, or those on anticoagulants.

Hyaluronic Acid for Long-Term Joint Health

What if our patient doesn’t have an acute flare? What if they present with more chronic, persistent pain and want to improve the long-term health of their joint? This is where we shift our focus from just putting out the fire of inflammation to improving the joint’s structural environment. A primary candidate for this goal is hyaluronic acid (HA), also known as viscosupplementation.

The core concept behind HA injections is to augment the natural viscoelastic properties of the synovial fluid. In an osteoarthritic joint, the natural endogenous HA is depleted and degraded. This reduces the fluid’s viscosity and lubricating properties. By supplementing it with an injection, we aim to:

Improve joint lubrication and shock absorption.
Modulate nociception (pain signaling) and inflammation.

HA works through several biological pathways. It binds to a receptor on synovial cells, CD44, which in turn helps modulate inflammation by decreasing inflammatory cytokines such as IL-1β and cartilage-degrading enzymes such as MMPs. It also appears to stimulate the joint’s own cells to produce more of their natural HA and may have direct chondroprotective effects.

Clinical evidence shows that HA leads to a small but statistically significant reduction in knee OA pain compared to placebo. A comprehensive review by Jevsevar et al. (2015) showed that the pain-relieving effects tend to peak around two months and can last for six months or longer. The treatment appears to be most effective in patients under 65, those with a higher BMI, more severe baseline symptoms, and lower radiographic severity.

It’s important to note that not all HA is created equal. Molecular weight matters. Basic science shows that high-molecular-weight HA has a more profound chondroprotective effect, a greater ability to reduce inflammation through the CD44 pathway, and is better at stimulating the body’s own HA production compared to low-molecular-weight formulations. This is a critical factor I consider when selecting a product for my patients.

Despite this evidence, there is no unified stance on HA. While many European societies accept its use, leading U.S. organizations like the American Academy of Orthopedic Surgeons (AAOS) generally discourage it, citing that the clinical benefit is not consistently large enough. As a result, many insurance companies no longer provide coverage, making it an out-of-pocket expense for many patients. While some studies suggest HA can delay the need for knee replacement surgery, it is not considered a true disease-modifying treatment. This leads us to the next logical step in our journey: biologics.

Platelet-Rich Plasma (PRP): A True Disease-Modifying Potential

If we are looking for an injection that can both treat pain effectively and potentially modify the disease process itself, the strongest evidence currently points to Platelet-Rich Plasma (PRP).

PRP is a concentrate of platelets derived from the patient’s own blood. These platelets are a reservoir of powerful growth factors and signaling molecules that orchestrate tissue healing. When injected into an osteoarthritic knee, PRP has multiple effects:

Modulates Inflammation: It influences key inflammatory pathways, such as NF-kappa B, shifting the joint environment from a pro-inflammatory (M1 macrophage) state to an anti-inflammatory and regenerative (M2 macrophage) state.
Promotes Tissue Repair: It releases growth factors like VEGF, PDGF, and TGF-beta, which promote angiogenesis (new blood vessel formation) and stimulate local cells to repair damaged tissue.
Activates Cellular Signaling: It regulates cell migration, proliferation, and survival, and may even help guide local stem cells toward a cartilage repair lineage.

Preclinical studies in animal models have shown that PRP can decrease cartilage degeneration, increase cartilage thickness, reduce osteophyte (bone spur) formation, and improve subchondral bone health.

The clinical evidence for PRP in knee OA is vast and robust. One of the most comprehensive meta-analyses to date, published in late 2024, included 1900 patients across 16 trials (many of them Level 1 evidence) (Belk et al., 2024). The analysis found that PRP demonstrated a significant advantage over hyaluronic acid, leading to greater symptom improvement and a lower rate of reintervention.

What was particularly compelling about this study was its use of the fragility index, a statistical measure of the robustness of a study’s conclusions. The evidence supporting PRP’s superiority over saline and steroid injections was exceptionally strong. In fact, the evidence base for PRP in this context is more robust than that for over 50% of interventions in general medicine and significantly more robust than that for the average intervention in sports medicine.

A crucial question for any OA treatment is whether it can delay surgery. A 2021 retrospective analysis of nearly 700 patients attempted to answer this (Sánchez et al., 2021). The results were profound:

85% of patients did not undergo a total knee replacement during the five-year follow-up period.
For those who did eventually need surgery, the median delay was 5.3 years.
Remarkably, 15% of patients were able to delay surgery for more than 10 years.

The Critical Role of Dose in PRP for Regenerative Medicine

The journey with PRP has had its ups and downs. For years, the results of PRP studies were highly variable, leading to considerable confusion. Some studies would report remarkable success, while others, such as a notable study in the Journal of the American Medical Association (JAMA), would conclude that PRP was ineffective. This left us with a critical question: why the discrepancy? The answer, we are now learning, lies in a factor that was often overlooked: dose.

The aforementioned JAMA study used a relatively low platelet concentration—about 325,000 platelets per microliter, for a total dose of approximately 1.6 billion platelets. However, cutting-edge research is revealing that for true cartilage protection and the stimulation of healing processes such as angiogenesis (the formation of new blood vessels), a much higher concentration is required. The target we now aim for is 1.5 to 2 million platelets per microliter.

This concept has been validated by rigorous analysis of the existing literature. A systematic review my colleagues and I analyzed found a stark difference in outcomes based on dosage:

Studies with Positive Outcomes: Used an average total dose of 5.5 billion platelets.
Studies with Negative Outcomes: Used an average total dose of only 2.2 billion platelets.

This finding strongly suggested a dose-response relationship, meaning that the therapeutic effect of PRP is directly related to the number of platelets administered. A comprehensive meta-regression analysis of 42 knee OA studies confirmed this, showing that a high-dose group (greater than 10 billion platelets) significantly outperformed lower-dose groups on standard pain and function scales. The takeaway is clear: not all PRP is created equal. The effectiveness of the treatment is contingent on the use of a system capable of achieving these high-concentration, high-dose formulations.

PRP vs. Hyaluronic Acid (HA) for Osteoarthritis

Let’s return to a common clinical scenario: a patient with knee OA wants a healthier, long-term solution. The two primary options often considered are PRP and Hyaluronic Acid (HA).

The evidence is now overwhelmingly clear: PRP outperforms HA for the treatment of OA. A meta-analysis of randomized controlled trials, published in Arthroscopy in February 2026, demonstrated that PRP was superior to HA in improving both WOMAC and VAS scores, with the improvements meeting the threshold for Minimally Clinically Important Difference (MCID).

But does this mean HA has no role? Not necessarily. An exciting area of research is the combination of PRP and HA. The rationale is that their mechanisms are complementary:

PRP: Works on a biologic level, delivering a high concentration of growth factors that reduce inflammation and stimulate matrix synthesis.
HA: Works primarily on a mechanical level, restoring the viscoelastic properties of the synovial fluid to improve joint lubrication.

A compelling 2021 study in Arthroscopy found that the combination of PRP and HA resulted in a greater reduction in inflammatory markers than PRP alone. Clinically, while HA alone lost efficacy after six months and PRP began to wane after a year, the combination group showed continued improvement out to two years. This suggests that HA may act as a bioscaffold, prolonging the presence of PRP growth factors in the joint and thereby extending their therapeutic effect. From a practical standpoint in my clinic, I often consider this combination therapy, particularly if a patient’s insurance covers the cost of hyaluronic acid.

Comparative Look at Knee Injectables for OA

To summarize the key differences, let’s break down how each injectable option functions within the joint:

Mechanism	Platelet-Rich Plasma (PRP)	Corticosteroids	Hyaluronic Acid (HA)	Ketorolac (Toradol)
Chondroprotection	Excellent: Stimulates chondrocytes and protects cartilage.	Catabolic: Harmful to cartilage cells with repeated use.	Mild: Some protective effects.	None: No direct effect on cartilage.
Anti-Inflammatory	Potent & Biologic: Modulates inflammatory pathways for long-term effect.	Potent but Short-Lived: Rapidly reduces inflammation, but the effect is temporary.	Mild: Modest anti-inflammatory action.	Potent: Blocks COX enzymes for rapid pain and inflammation relief.
Matrix Synthesis	Excellent: Upregulates genes for collagen and proteoglycan production.	Inhibitory: Suppresses the synthesis of new cartilage matrix.	Modest: Small increase in matrix synthesis.	None: No benefit to matrix synthesis.
Viscoelastic Support	None: Does not improve joint lubrication.	None: No mechanical benefit.	Excellent: The primary mechanism is restoring joint fluid viscosity.	None: No mechanical benefit.
Longevity of Effect	Longest: Months to years.	Short: Weeks.	Moderate: 4 to 6 months.	Short: Weeks to a month.

The Role of Integrative Chiropractic Care

As a practitioner who integrates chiropractic care into my treatment plans, I see these advanced injections as powerful tools that work synergistically with our philosophy. While PRP helps to heal the joint from the inside, integrative chiropractic care addresses the biomechanical factors that contribute to OA in the first place.

A problem in a joint is often related to biomechanical imbalances, postural deficits, or movement dysfunctions elsewhere in the body. Chiropractic care is essential for:

Restoring Proper Biomechanics: Through spinal and extremity adjustments, we correct joint misalignments that place abnormal stress on the knee, addressing the root cause of the overload. Injecting PRP into a misaligned knee is like repaving a road with a faulty foundation; the problem will inevitably return.
Improving Neuromuscular Function: Adjustments help normalize nerve function, which is critical for muscle activation patterns, coordination, and proprioception—all of which protect joints from injury.
Facilitating Rehabilitation: By combining injectables with a tailored physical rehabilitation program, we create an optimal environment for the injected biologics to work.

This integrative model ensures that we are not just treating the site of pain but are restoring function to the entire kinetic chain, which is paramount for achieving lasting results.

Conclusion: A Personalized, Evidence-Based Approach

So, returning to our 60-year-old patient with the wedding next week, what is the best choice?

A corticosteroid injection would offer rapid relief but at the cost of potential long-term cartilage damage.
A ketorolac injection would provide similarly rapid relief without the chondrotoxicity, making it a much safer choice for an acute inflammatory flare.
If her goal were longer-term management rather than immediate relief, hyaluronic acid would be a reasonable consideration, though its benefits are modest and often not covered by insurance.
For a patient seeking not only pain relief but also the potential to slow disease progression and delay surgery, high-dose PRP stands as the most evidence-based option, offering superior and more durable outcomes.

In my practice, the journey doesn’t end with an injection. It’s about creating a comprehensive, personalized treatment plan. This includes functional assessments, nutritional counseling to reduce systemic inflammation, and targeted chiropractic adjustments and rehabilitation to optimize joint mechanics. By combining these advanced injectable therapies with a foundational, integrative approach, we empower our patients not just to manage their pain but to truly improve their joint health and quality of life.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

References

SEO Tags: knee osteoarthritis, knee pain, intra-articular injections, corticosteroid, chondrotoxicity, ketorolac, hyaluronic acid, viscosupplementation, PRP, platelet-rich plasma, regenerative medicine, integrative chiropractic, Dr. Alexander Jimenez, knee OA treatment, PRP dose, high-dose PRP, non-surgical knee treatment, evidence-based medicine, functional medicine, joint health, cartilage protection

May 7, 2026

Autologous Platelet Therapy Benefits for Musculoskeletal Care

Learn about the innovative approaches in musculoskeletal care with autologous platelet therapy and how it benefits patient recovery.

Abstract

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, share a practical, step-by-step roadmap for preparing and using modern autologous biologics—specifically platelet-rich plasma (PRP) and protein concentrate (PC)—to treat musculoskeletal pain, tendinopathies, and knee osteoarthritis. I explain, in plain language, how anticoagulants like ACD-A, centrifugation parameters (RCF and time), and careful buffy coat handling determine platelet integrity, leukocyte content, and clinical performance. I also show how integrative chiropractic care—spinal and extremity adjustments, myofascial work, shockwave therapy, laser photobiomodulation, and graded loading—creates the mechanical and neurophysiological context that enables PRP and PC to deliver durable results. Drawing on rigorous, peer-reviewed research and my own clinical observations from practice in El Paso and collaborative networks, I present safety protocols, dosing logic, workflow checklists, and return-to-function pathways that patients and clinicians can use immediately.

Why PRP And PC Belong In Modern Musculoskeletal Care

As a clinician at the intersection of chiropractic medicine, advanced practice nursing, and functional medicine, my goal is to accelerate tissue repair while safeguarding joint integrity and long-term function. Over the past decade, PRP has matured from a promising concept to a therapy with growing support for specific indications, notably chronic tendinopathy and early-to-moderate knee osteoarthritis when protocols are standardized and paired with rehabilitation (Fitzpatrick et al., 2017; Murray et al., 2020). In our El Paso clinic, I increasingly integrate PRP with protein concentrate (PC)—a concentrated fraction derived from platelet-poor plasma—to enhance anti-inflammatory protein density and complement PRP’s growth factor payload.
What PRP does: Platelets deliver a coordinated set of bioactive signals—PDGF, TGF-β, VEGF, IGF-1, and others—that recruit reparative cells, modulate inflammation, stimulate angiogenesis, and upregulate extracellular matrix synthesis in tendons, ligaments, and cartilage (Murray et al., 2020).
What PC adds: By removing water from PPP through a controlled filtration step (typically with ~15 kDa cut-off membranes), we enrich proteins like albumin, fibronectin, and alpha-2-macroglobulin (A2M). This can increase injectate viscosity, potentially inhibit catabolic proteases, and support symptom modulation in degenerative joints—complementing PRP’s anabolic signaling.
Most importantly, biologics work best when the body’s mechanics and neuroimmune balance support healing. This is where integrative chiropractic care amplifies outcomes: restoring joint motion, optimizing load distribution, calming nociceptive drive, and guiding collagen remodeling through progressive, tissue-specific loading.

The Physiology Of PRP: Why Anticoagulants And Spin Settings Matter

Platelets are not just clotting cells; they are mobile drug-delivery systems. Their alpha-granules house the growth factors and cytokines that direct early inflammation, angiogenesis, and matrix deposition. To preserve this potential:
We use ACD-A (acid-citrate-dextrose solution A) to chelate calcium and prevent premature clotting. The acidic environment keeps platelets quiescent, preserving membrane integrity and the kinetics of growth factor release upon tissue exposure (Textor & Taber, 2020).
We standardize centrifugation using RCF (g) rather than rpm because rotor radius affects the rpm-to-g translation. Targeting validated RCF bands yields consistent separation of RBCs, the buffy coat, and PPP. It allows us to choose leukocyte-rich (LR-PRP) or leukocyte-poor (LP-PRP) profiles based on the indication (Chahla et al., 2020).
Why precision is non-negotiable:
Too much g-force or time can pre-activate platelets, spilling growth factors in the tube rather than the tissue.
Too little separation results in an under-concentrated product that may not meet dose thresholds associated with better outcomes (Fitzpatrick et al., 2017).
Leukocyte content shapes the inflammatory milieu. LR-PRP can be helpful for chronic tendinopathy; LP-PRP is often favored for intra-articular administration to reduce synovial flares (Mathesul et al., 2022; Chahla et al., 2020).

Step-By-Step PRP Workflow: From Venous Draw To Final Injectate

I design our workflow to be reproducible in a busy clinic and gentle on the biologic product.
Preparation
Confirm kit integrity, lot numbers, and expiration dates.
Preload ACD-A into the collection system (for example, 5–6 cc in a 60-cc draw, when feasible).
Set up a sterile field and label everything before the draw.
Phlebotomy and Handling
Prefer an 18-gauge or appropriately sized needle to ensure a steady flow without excessive shear.
Mix blood with ACD-A via gentle inversion (5–10 times). Avoid shaking or rapid aspiration that can activate platelets or hemolyze cells.
If venous access is challenging, hydrate the patient in advance and consider a butterfly set with ultrasound guidance.
Centrifugation
Balance paired tubes within 1 gram to limit vibration and shear. Imbalance increases oscillatory forces that can damage platelets.
Use a validated protocol. For many musculoskeletal uses, a single spin at a defined RCF for 10 minutes yields a clean separation into RBCs, a visible buffy coat, and PPP. Systems differ; always standardize by RCF.
If the clinical goal requires a higher concentration or specific leukocyte tailoring, a double-spin protocol can be used judiciously, with activation risk in mind.
Harvesting The Buffy Coat
After spin, the buffy coat is the platelet-rich layer at the RBC-plasma interface. Using a 10 cc syringe, harvest with minimal RBC contamination. A faint salmon hue is acceptable; frank red is not.
For LR-PRP (tendons), dip slightly deeper toward the interface; for LP-PRP (joints), harvest more superficially from the plasma side.
Protein Concentrate From PPP
Process PPP through a pre-moistened filter with a ~15-kDa cut-off. Pre-moistening minimizes nonspecific protein adsorption.
Gently remove ~70–75% of the water content using controlled push-pull through the filter, thereby increasing the relative concentration of beneficial proteins, including A2M and fibronectin.
The resulting PC provides additional injectate volume and a protein-rich milieu that can modulate inflammation and lubricate articular surfaces.
Final Assembly
Decide whether to inject PRP and PC separately or gently homogenize measured volumes using a sterile connector. Mix slowly to avoid shear.
Use ultrasound guidance for precise placement—tendon hypoechoic zones, paratenon planes, or intra-articular spaces.
Clinical reasoning behind each step:
Anticoagulation preserves growth factor payload until the tissue triggers platelet activation.
Centrifuge balance and appropriate RCF protect platelet morphology and reduce unwanted leukocyte shifts.
Leukocyte tailoring aligns the biologic with the tissue’s inflammatory tolerance and remodeling needs.
PC complements PRP by inhibiting proteases and improving the rheology of the injectate, which is especially useful in early OA phenotypes.

Matching PRP Formulation To Pathology: LR-PRP Versus LP-PRP

Deciding between leukocyte-rich and leukocyte-poor PRP is a clinical fulcrum point.
LR-PRP for chronic tendinopathy
Rationale: A brief, targeted inflammatory spark can restart stalled healing, recruit macrophages, and stimulate tenocytes to produce new matrix (Fitzpatrick et al., 2017).
Application: Lateral epicondylalgia, patellar tendinopathy, proximal hamstring tendinopathy, and Achilles tendinopathy in non-irritable phases.
Caveats: Expect more post-injection soreness during days 1–3; plan analgesia and loading accordingly.
LP-PRP for intra-articular applications
Rationale: Minimizes synovial irritation while delivering anabolic signals that support chondrocyte activity and symptom relief (Mathesul et al., 2022).
Application: Knee osteoarthritis and other joints prone to inflammatory flares.
Synergy: LP-PRP + PC can offer additional symptom control via protease inhibition and improved viscoelastic properties.

Protein Concentrate: Extending The Therapeutic Window

After PRP separation, we convert PPP into a protein concentrate to increase the per-injection protein density of albumin, fibronectin, and alpha-2-macroglobulin. Why this matters:
Protease modulation: In osteoarthritic joints, catabolic enzymes degrade the matrix. A2M acts as a broad-spectrum protease inhibitor, potentially shifting the balance toward repair.
Matrix support: Fibronectin aids cell adhesion and matrix assembly, supporting collagen alignment under load.
Symptom modulation: Concentrated proteins can improve injectate lubrication and reduce irritative symptoms between PRP rounds.
In my practice, PC serves as a versatile adjunct—expanding injectable volume for multi-site care without diluting the platelet dose and providing a biologically supportive environment for tissue remodeling.

Patient Preparation, Safety, And Vasovagal Readiness

Real clinics treat real people—some are needle-averse, and a subset are prone to vasovagal syncope. We normalize and prepare:
Screening: Ask explicitly about a history of fainting. If a patient says, “I am a fainter,” we believe them and plan.
Positioning: Supine or semi-recumbent for draws and injections when indicated, with leg elevation available.
Hydration and nutrition: Encourage hydration 24 hours before, unless contraindicated. This improves venous access and stabilizes layers during spin.
Medication review: Avoid NSAIDs and aspirin pre- and post-procedure when clinically appropriate to preserve platelet function (Patrono & Rocca, 2008). Acetaminophen and topical measures are preferred for pain in the early window.
Calm environment: Dim lights, paced breathing, and gentle narration reduce sympathetic spikes and post-episode fatigue.
A smooth experience supports adherence throughout the 6–12-week remodeling arc, which is essential for functional gains.

Integrative Chiropractic Care: The Biomechanical Force Multiplier

Biologics supply the biochemical instructions; movement and alignment tell tissues how to read them. I integrate chiropractic care before and after injections to align cellular and mechanical healing.
Spinal and extremity adjustments
Goal: Restore joint play, reduce aberrant loading, and normalize afferent input. Better arthrokinematics reduce paratenon friction and focal tendon stress.
Physiology: Optimized mechanics improve mechanotransduction, allowing tenocytes and chondrocytes to interpret growth factor signals under appropriate strain (Khan & Scott, 2009).
Myofascial and neurodynamic work
Goal: Restore fascial glide and reduce neural mechanosensitivity that perpetuates guarding and pain.
Payoff: Reduces nociceptive noise and central sensitization, smoothing the early inflammatory-to-proliferative transition post-PRP.
Shockwave therapy
Evidence: Shockwave improves tenocyte activity, neovascularization, and nociceptive modulation in chronic tendinopathy (Laudy et al., 2015).
Timing: Often introduced after the initial inflammatory window, it can reinforce matrix turnover initiated by PRP.
Photobiomodulation (high-intensity laser)
Mechanism: Red/NIR light can enhance mitochondrial respiration via cytochrome c oxidase, improve perfusion, and modulate oxidative stress.
Role: Supports energy demands and pain control during weeks 1–2 when tissues are transitioning into proliferation.
Graded loading and neuromuscular re-education
Sequence: Isometrics for early analgesia, then eccentrics to organize collagen, followed by concentric and plyometric phases as tolerated (Khan & Scott, 2009).
Principle: Tissues remodel along lines of stress. We give them the right stress at the right time.
From my clinic observations at ChiroMed and collaborations documented on my professional channels, patients who receive PRP plus a coherent chiropractic-guided loading plan routinely achieve faster, more durable gains than those who receive injection alone. See clinical updates and case patterns at my practice website and professional profile (Jimenez, n.d.-a; Jimenez, n.d.-b).

Dosing, Volumes, And Timing: Making Every Platelet Count

Does precision matter more than any single concentration number? From a 60 mL whole blood draw, many systems yield roughly 6–7 mL of PRP and an additional 2–4 mL of PC after filtration—enough for a focused tendon program or a knee joint plus peritendinous adjuncts.
Platelet dose: The literature supports aiming for a platelet count threshold associated with improved outcomes in tendinopathy and knee OA, acknowledging system variability (Fitzpatrick et al., 2017; Rabago & Nourani, 2017).
Intervals: Joints commonly respond to 1–3 PRP sessions spaced 4–8 weeks apart, especially when integrated with mechanical correction and strengthening. Symptom relief in knee OA can extend 6–12 months in responders (Saltzman et al., 2016).
PC timing: PC can help maintain symptom control between PRP rounds, particularly in active patients, targeting return-to-play milestones in 4–6 weeks, when mechanics and loading are well controlled.
When a smaller draw (35–40 mL) is all a patient can tolerate, I prioritize the most symptomatic target, amplify the mechanical program, and carefully allocate injectate volume to where it will be most impactful.

Chiropractic Solutions for Osteoarthritis-Video

Post-Procedure Roadmap: From Inflammation To Remodeling

Healing unfolds in phases that we respect and leverage.
Days 0–3: Inflammatory
Expected: Fullness, ache, mild swelling as platelets degranulate.
Plan: Protect the site; avoid NSAIDs unless medically necessary; consider acetaminophen and topical care. Use light mobility and breathing to downshift sympathetic tone.
Days 3–10: Early proliferative
Introduce: Isometrics for tendon analgesia, gentle joint mobilizations as indicated, and low-load tissue exposure.
Weeks 2–6: Proliferative
Progress: Eccentrics and tempo-controlled loading. Add shockwave and manual therapy to restore fascial gliding and reinforce collagen organization.
Weeks 6–12: Remodeling
Integrate: Concentric and energy-storage drills for tendons. Restore kinetic-chain control—hip abductors for knee, scapular control for shoulder, foot intrinsics for Achilles.
Beyond 12 weeks
Return to sport or high-demand tasks with periodic reassessment. Consider a PC boost to modulate symptoms in select OA phenotypes.
This framework capitalizes on PRP’s early signaling and aligns tissue loading with collagen maturation and alignment.

Safety, Ultrasound Guidance, And Documentation

Safety is the floor, not the ceiling.
Aseptic technique: Single-use kits, sterile fields, and ultrasound-guided placement are standard in our clinic.
Ultrasound guidance: Increases accuracy, reduces off-target irritation, and ensures injectate reaches hypoechoic degenerative zones or joint spaces precisely.
Compliance and traceability: We document consent, kit lots, spin parameters (RCF/time), volumes at each stage, and injection details in the EHR. This supports quality assurance and continuous improvement.

Clinical Observations From My Practice

Across my patient panels and collaborative work:
Knee OA with valgus collapse: LP-PRP plus PC fares far better when we also correct foot-ankle mechanics, mobilize the hip, and retrain frontal-plane control. Durable symptom relief tracks with durable biomechanical correction.
Chronic Achilles tendinopathy: Respect tissue irritability. Avoid aggressive stretching immediately post-PRP. Use isometrics for analgesia, progress to heavy-slow resistance, and add plyometrics after week 6, guided by reactivity. Outcomes improve when we follow this cadence.
Desk-bound lateral epicondylalgia: Ergonomics, cervicothoracic mobility, and local tendon loading paired with LR-PRP produce stronger, more durable pain relief than injection alone.
For ongoing case narratives and data-informed reflections, see my clinic resources and professional updates (Jimenez, n.d.-a; Jimenez, n.d.-b).

Troubleshooting And Practical Pearls

Difficult venipuncture: Warm compress, dependent positioning, and ultrasound assistance. Reschedule rather than force a hemolyzing draw.
Clotting in tube: Ensure prompt, gentle mixing with ACD-A; minimize dwell time before spin.
Low platelet yield: Reassess RCF calibration, balance, and harvest technique. Consider double-spin if indicated by protocol.
Patient anxiety: Supine positioning, vibration distraction near the site, and paced breathing reduce sympathetic surges and improve tolerance.
Each solution maps to a physiologic principle: protecting platelet integrity, maintaining layer purity, and stabilizing autonomic balance.

Evidence Snapshot: What Leading Researchers Show

PRP improves pain and function in chronic tendinopathy and offers advantages over comparators in selected knee OA cohorts when properly formulated and delivered with rehab (Fitzpatrick et al., 2017; Saltzman et al., 2016; Rabago & Nourani, 2017).
Leukocyte tailoring matters: LP-PRP generally outperforms or is better tolerated when administered intra-articularly, whereas LR-PRP can benefit recalcitrant tendon pathology (Chahla et al., 2020; Mathesul et al., 2022; Filardo et al., 2018).
Multimodal care—shockwave, photobiomodulation, and structured loading—enhances outcomes beyond injection alone (Laudy et al., 2015; Tumilty et al., 2010; Khan & Scott, 2009).
Standardization is key. Reporting RCF, leukocyte, and platelet counts, and activation status makes methods reproducible and results translatable from clinic to clinic (Chahla et al., 2019).

Putting It All Together: A Patient-Centered, Systems Approach

Our integrative pathway is simple in concept and precise in execution:
Use PRP to catalyze anabolic signaling.
Add PC to concentrate protective proteins and support joint microenvironments.
Deploy ultrasound-guided injections for precision.
Align biomechanics with spinal and extremity adjustments, fascial work, and neurodynamics.
Guide collagen remodeling with staged isometric-to-eccentric-to-plyometric loading.
Support cellular energy and recovery with photobiomodulation, sleep optimization, hydration, and protein-forward nutrition.
When these elements synchronize, I consistently see faster pain relief, stronger functional gains, and longer-lasting results.

References

Chahla, J., Cinque, M. E., Piuzzi, N. S., et al. (2020). PRP formulations: Impact of leukocytes on clinical outcomes. Arthroscopy, 36(11), 2820–2832. https://doi.org/10.1016/j.arthro.2020.06.029
Chahla, J., Cinque, M. E., Piuzzi, N. S., et al. (2019). A call for standardization in platelet-rich plasma preparation protocols and composition reporting. Sports Medicine, 49(6), 1007–1019.
Filardo, G., Di Matteo, B., Di Martino, A., Merli, M. L., & Kon, E. (2018). Platelet-rich plasma in tendon-related disorders: Results and indications. Knee Surgery, Sports Traumatology, Arthroscopy, 26(7), 1984–1999.
Fitzpatrick, J., Bulsara, M., & Zheng, M. H. (2017). The effectiveness of platelet-rich plasma in the treatment of tendinopathy. British Journal of Sports Medicine, 51(23), 1740–1747.
Khan, K. M., & Scott, A. (2009). Mechanotherapy: How physical therapists’ prescription of exercise promotes tissue repair. British Journal of Sports Medicine, 43(4), 247–252. https://doi.org/10.1136/bjsm.2008.054239
Laudy, A. B., Bakker, E. W., Rekers, M., & Moen, M. H. (2015). Efficacy of extracorporeal shockwave therapy in musculoskeletal disorders. British Journal of Sports Medicine, 49(19), 1241–1250.
Mathesul, A. A., et al. (2022). Leukocyte-poor versus leukocyte-rich PRP for knee osteoarthritis: A systematic review and meta-analysis. Knee Surgery, Sports Traumatology, Arthroscopy, 30, 381–397.
Murray, I. R., LaPrade, R. F., Geeslin, A. G., et al. (2020). Platelet-rich plasma and the musculoskeletal system: Mechanisms and clinical perspectives. Journal of Orthopedic Research, 38(10), 2259–2272. https://doi.org/10.1002/jor.24774
Patrono, C., & Rocca, B. (2008). Aspirin and other COX-1 inhibitors: Mechanisms, clinical endpoints, and patient considerations. Thrombosis Research, 123(1), 15–25.
Rabago, D., & Nourani, B. (2017). PRP for osteoarthritis: Concise review of evidence and recommendations. PM&R, 9(7), S149–S164.
Saltzman, B. M., et al. (2016). PRP for knee osteoarthritis: Systematic review. Orthopedic Journal of Sports Medicine, 4(11), 2325967116674921.
Textor, S. C., & Taber, D. J. (2020). Regenerative injection therapies: Practical considerations for PRP preparation. PM&R Clinics, 12(2), 283–299.
Tumilty, S., et al. (2010). Low-level laser therapy for tendinopathy: A systematic review. British Journal of Sports Medicine, 44(9), 763–771.
Jimenez, A. (n.d.-a). Clinical insights and cases at ChiroMed.
Jimenez, A. (n.d.-b). Professional profile and integrative practice updates.

SEO tags

platelet-rich plasma, PRP, protein concentrate, PPP, ACD-A, leukocyte-poor PRP, leukocyte-rich PRP, centrifugation RCF, buffy coat, ultrasound-guided injection, chiropractic integration, mechanotransduction, shockwave therapy, photobiomodulation, tendon healing, knee osteoarthritis, regenerative medicine, functional rehabilitation, El Paso chiropractor, Dr. Alexander Jimenez

March 16, 2026

Platelet-Rich Plasma Therapy Supports Detoxification

(PRP) Therapy Healing at ChiroMed Integrated Medicine

Platelet-Rich Plasma, or PRP, is a treatment that uses your blood to help your body heal. At ChiroMed Integrated Medicine in El Paso, Texas, doctors draw a small amount of blood, spin it to concentrate the platelets, and inject the plasma into the hurt area. Platelets are small blood cells that help with clotting and carry growth factors. These factors start the body’s repair process. PRP is great for joint pain, tendon issues, and skin problems because it speeds healing without drugs or surgery.

PRP helps with detoxification and cleanup in the body. Detoxification removes waste and damaged parts from tissues. Cleanup removes dead cells and debris to promote new tissue growth. PRP releases growth factors that start healing. It forms new blood vessels, a process known as angiogenesis, to deliver oxygen and nutrients and remove waste. It draws in macrophages to eat up harmful debris and boosts fibroblasts to rebuild cellular support. It also helps control inflammation, preventing long-term swelling. This makes PRP a natural way to balance the body, fitting ChiroMed’s holistic approach.

Studies show PRP’s growth factors promote cell growth and cut swelling, aiding waste removal (Foster et al., 2010). PRP activates paths for new tissue and debris cleanup (Desert Spine and Sports, n.d.).

Key Ways PRP Works for Detox and Repair

PRP boosts the body’s repair system. When injected, platelets release growth factors like Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-Beta (TGF-β), Vascular Endothelial Growth Factor (VEGF), and Insulin-Like Growth Factor-1 (IGF-1). Each helps clean and rebuild.

Here are the main ways PRP aids detoxification and cleanup:

Initiating Angiogenesis: VEGF stimulates the formation of new blood vessels. This boosts blood flow, delivering nutrients and oxygen while flushing metabolic debris, which is junk from hurt cells (Caring Medical, n.d.).
Drawing in Macrophages: PDGF attracts macrophages, the cleanup cells. They eat dead cells, bacteria, and damaged tissue via phagocytosis. This clears space for new cells and stops harmful buildup (Hospital for Special Surgery, n.d.).
Boosting Fibroblast Work: Fibroblasts produce collagen and help maintain the extracellular matrix, the tissue scaffold. TGF-β and IGF-1 push these cells to repair, removing old scars and adding healthy structure (Sampson et al., 2010).
Balancing Inflammation: PRP causes a brief inflammatory response to signal healing, then calms it. This removes debris without extra damage. TGF-β helps prevent chronic swelling, creating a clean regeneration space (Action Medical Center, n.d.).
Encouraging Cell Growth: Factors such as Epidermal Growth Factor (EGF) promote cell division and the replacement of old cells. This accelerates waste removal and tissue repair, especially in slow-healing areas such as tendons and cartilage (Desert Spine and Sports, n.d.).

These steps form a healing cascade. PRP is safe, biological, and from your body. It restores homeostasis, aligning with ChiroMed’s focus on natural, integrated care.

PRP Benefits for Tissue Renewal at ChiroMed

At ChiroMed, PRP offers benefits for injuries and chronic conditions. It speeds recovery using your body’s tools, cutting the need for pain pills or big treatments. For knees, PRP eases pain and improves mobility by regenerating cartilage and clearing waste (Integrative Medicine Care, n.d.). It’s also used on the skin to increase collagen for better texture and remove damaged cells (Willow Medical, n.d.).

Benefits include:

Quicker Healing: PRP shortens recovery by fast debris removal and growth. It helps wounds, tendons, and arthritis (Mishra et al., 2018).
Less Pain: It regulates inflammation and strengthens tissues, easing chronic pain without steroids that just hide symptoms (Washington University Orthopedics, n.d.).
Better Movement: New vessels and matrix fixes improve mobility and strength in muscles, ligaments, and joints (Cedars-Sinai, n.d.).
Safe and Natural: From your blood, low rejection risk. It boosts resilience through healthy habits, aligning with ChiroMed’s naturopathy and nutrition (Integrative Medicine Care, n.d.).
Wide Uses: From sports injuries to degeneration, PRP aids hair growth or scar reduction (Advanced Chiropractic Clinic, n.d.).

PRP enhances ChiroMed’s holistic services for overall health.

Using PRP in ChiroMed’s Integrated Care

ChiroMed Integrated Medicine uses PRP with expert guidance for the best results. Their team, including APRNs and FNPs with CFMP training, provides targeted, image-guided injections and holistic support, such as nutrition for metabolic cleanup (Ultrasound Guided Injections, n.d.). This multidisciplinary method supports PRP’s cleanup and repair, leading to better rejuvenation.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN, leads at ChiroMed. With 30+ years of experience, he uses PRP for knee osteoarthritis and injuries, noting reduced inflammation and improved repair with chiropractic and functional medicine (Jimenez, n.d.a; Jimenez, n.d.b). His work shows quicker recovery for sports or auto injuries, focusing on root causes for natural detox. Dr. Jimenez blends PRP with rehab, metabolic support, nutrition, acupuncture, and naturopathy for full healing without surgery.

ChiroMed’s approach combines conventional and alternative medicine for chronic pain, back issues, sciatica, and more. PRP fits their patient-centered plans, using evidence-based methods in a welcoming space.

PRP Limits and Tips

PRP helps, but it isn’t for all. Results depend on health, injury level, and prep. It may not be suitable for severe cases such as advanced cancer or blood disorders (Perfect Drs, n.d.). Rare side effects include swelling or infection. Sessions may be multiple and not always insured (Advanced Chiropractic Clinic, n.d.).

Studies vary due to methods (Sampson et al., 2010). Talk to ChiroMed doctors to check if it fits.

Wrapping Up

PRP therapy uses your body’s power for detox and cleanup at ChiroMed. Concentrated growth factors speed healing, clear debris, and rebuild tissues. From angiogenesis to macrophages, it sets the stage for clean regeneration. ChiroMed, led by Dr. Jimenez, combines PRP with holistic care for optimal outcomes. For pain or injury, PRP at ChiroMed could aid natural recovery.

References

Advanced Chiropractic Clinic (n.d.). Platelet Rich Plasma (PRP).
Action Medical Center (n.d.). How PRP Therapy Works: Mechanisms Explained.
Caring Medical (n.d.). What is Platelet Rich Plasma Therapy?.
Cedars-Sinai (n.d.). Platelet Rich Plasma Therapy.
Cleveland Clinic (n.d.). Are PRP Injections Worth It?.
Desert Spine and Sports (n.d.). The Science of PRP: How Platelet Rich Plasma Therapy Works.
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2010). Platelet-Rich Plasma: From Basic Science to Clinical Applications. PMC, PMC3445108. https://pmc.ncbi.nlm.nih.gov/articles/PMC3445108/
Hospital for Special Surgery (n.d.). Platelet-Rich Plasma (PRP) Injection: How It Works.
Integrative Medicine Care (n.d.). Harnessing the Power of PRP: How Platelet-Rich Plasma Supports Natural Healing.
Jimenez, A. (n.d.a). Injury Specialists. https://dralexjimenez.com/
Jimenez, A. (n.d.b). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN ♛ – Injury Medical Clinic PA | LinkedIn. https://www.linkedin.com/in/dralexjimenez/
Mishra, A., et al. (2018). Stem-cell therapy and platelet-rich plasma in regenerative medicines: A review on pros and cons of the technologies. PMC, PMC6306612. https://pmc.ncbi.nlm.nih.gov/articles/PMC6306612/
Perfect Drs (n.d.). What Are The PRP Treatment Limitations?.
Sampson, S., Gerhardt, M., & Mandelbaum, B. (2010). Platelet rich plasma injection grafts for musculoskeletal injuries: a review. PMC, PMC5329835. https://pmc.ncbi.nlm.nih.gov/articles/PMC5329835/
Ultrasound Guided Injections (n.d.). What is platelet rich plasma?.
Washington University Orthopedics (n.d.). Platelet-Rich Plasma (PRP) Helps the Body Repair Itself.
Willow Medical (n.d.). What is PRP? Platelet-Rich Plasma (PRP) is a blood component that contains high concentrations of platelets.

Tag: platelet-rich plasma

Abstract

The Foundation of Healing: Why Patient Optimization is Non-Negotiable

The Six Pillars of Lifestyle Medicine in Regenerative Care

Identifying and Addressing Key Barriers to Healing

Fueling Regeneration: The Power of an Anti-Inflammatory Diet

Proposed Dietary Approach

Do We Need Supplements?

Movement as Medicine: Exercise Protocols for Enhanced Healing

Exercise Recommendations

The Healing Diet: Combat Inflammation, Embrace Wellness- Video

The Critical Role of Restorative Sleep

Eliminating Toxic Burdens: Tobacco and Alcohol

The Biopsychosocial Model: Stress, Social Connection, and Pain

The Role of Integrative Chiropractic Care

A Practical Approach to Pre-Procedure Assessment

Initial Screening:

Screening Questionnaires:

Creating an Optimization Plan

References

Abstract

The Evolution of PRP: Beyond Leukocyte Ratios to Precise Dosing

A Paradigm Shift in Understanding

The Intricate Cellular Symphony Within PRP

Understanding the Buffy Coat and Its Components

The Crucial Role of Integrative Chiropractic Care

Creating an Optimal Healing Environment

A New Frontier in Regenerative Orthopedics

References

Abstract

What Is a Platelet and Why Does It Matter?

The Problem of Variability in PRP Preparations

The Evidence for PRP: A Growing Body of Research

How We Create Your Personalized PRP Treatment in Our Clinic

The Critical Concept of PRP Dosing

Dosing for Tendons and Soft Tissues

How Patient Age Impacts Dosing

Dosing for Knee Osteoarthritis (OA)

Beyond Platelets: The Role of White and Red Blood Cells

The Integral Role of Chiropractic Care and Rehabilitation

Key Takeaways for Patients and Practitioners

References

Abstract

Why We Seek Alternatives to Traditional Approaches

Understanding the Tools: Corticosteroids, HA, and PRP

Corticosteroids: The Double-Edged Sword

Hyaluronic Acid (HA): The Joint Lubricant

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

The Evidence: Comparing PRP, Steroids, and HA

PRP vs. Corticosteroids

PRP vs. Hyaluronic Acid (HA)

Summary of Evidence Table

Making the Right Choice: A Patient-Centered Approach

The Crucial Role of Integrative Chiropractic Care

Final Thoughts

References

Abstract

Introduction: Why Patients Ask About PRP Approval and Why Clinicians Need Clarity

FDA Status of PRP: What “Cleared” Means and Why PRP Itself Is Not Approved

Informed Consent and Ethical Language: How I Explain PRP Status

Optimizing PRP Quality: Exercise, Diet, and NSAIDs

NSAIDs Before and After PRP

Anti-Inflammatory Diet and Hydration

Blood Flow Restriction (BFR) and Pre-Draw Conditioning

What Counts Most: Dose, Product, and Indication

Physiological Underpinnings: Why PRP Works and Where It Struggles

Integrative Chiropractic Care: Synergy With PRP for Musculoskeletal Healing

Stepwise Integrated Protocol: From Consultation to Recovery

Clinical Observations From My Practice

What We Still Don’t Know—And How We Manage Uncertainty

Communicating With Patients: Clear, Confident, and Compassionate

Conclusion: A Practical, Ethical Path Forward for PRP

References

Abstract

The Cellular Orchestra: Understanding the Power Within Your Blood

Inside the Platelet: A Treasure Trove of Healing Granules

The Significance of Platelet Quality and “Dosing”

The Key Players: A Closer Look at Essential Growth Factors

Platelet-Derived Growth Factor (PDGF)

Transforming Growth Factor-Beta (TGF-β)